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Abstract
The ultimate goal of the present study is to aid in the development of tools to assist in the
treatment of cardiovascular disease. Gaining an understanding of hemodynamic parameters for
medical implants allow clinicians to have some patient-specific proposals for intervention
planning. In the present study a full cardiovascular experimental phantom and digital phantom
(CFD model) was fabricated to study: (1) the effects of local hemodynamics on global
hemodynamics, (2) the effects of transition from bed-rest to upright position, and (3) transport of
dye (drug delivery) in the arterial system.

Computational three dimensional (3-D) models

(designs A, B, and C) stents were also developed to study the effects of stent design on
hemodynamic flow and the effects of drug deposition into the arterial wall. The experimental
phantom used in the present study is the first system reported in literature to be used for
hemodynamic assessment in static and orthostatic posture changes.

Both the digital and

experimental phantom proved to provide different magnitudes of wall shear and normal stresses
in sections where previous studies have only analyzed single arteries.
The dye mass concentration study for the digital and experimental cardiovascular
phantom proved to be useful as a surrogate for medical drug dispersion.

The dye mass

concentration provided information such as transition time and drug trajectory paths. For the
stent design CFD studies, hemodynamic results (wall shear stress (WSS), normal stress, and
vorticity) were assessed to determine if simplified stented geometries can be used as a surrogate
for patient-specific geometries and the role of stent design on flow. Substantial differences in
hemodynamic parameters were found to exist which confirms the need for patient-specific
modeling. For drug eluting stent studies, the total deposition time for the drug into the arterial
wall was approximately 3.5 months.

2
1 CHAPTER 1
Introduction

Cardiovascular disease (CVD) remains to be the prominent cause of morbidity and
mortality across the world and improved methods for cardiovascular disease management are
deeply needed (Ricotta, Pagan et al. 2008). In the year 2000, cardiovascular disease accounted
for 39% of all deaths in America, and 32.4% in 2006, producing a health care cost of $430
billion per year (Daviglus 2005, Kung 2005, Murray 2006, Rosamond, Flegal et al. 2007). The
most common form of cardiovascular disease is coronary heart disease (CHD), also referred to as
atherosclerosis. Atherosclerosis is a disorder in which fatty deposits develop in an artery,
obstruct the lumen, and cause deformation and deterioration of the arterial wall.

Critical

conditions arise when atherosclerosis occurs in the coronary arteries and threatens to reduce
blood flow to the myocardium. The reduction of blood flow to the heart forces the heart to
produce more work and undergo stress, which eventually leads to heart failure. The result of
reduced blood flow and stress to the heart is angina pectoris (chest pain) or myocardial infarction
(heart attack). Also, the reduction of oxygen-rich blood to the brain results in brain cell death
(stroke).
The carotid bifurcation, where the common carotid artery (CCA) branches into the
internal carotid artery (ICA) and external carotid artery (ECA) is a common site of
atherosclerotic disease (Hewlin and Kizito 2011). Stenosis or narrowing of the ICA has long
been known to be related to the incidence of ischemic stroke (Barnette et al. 200; Fisher 1951).
In severe atherosclerosis, plaque buildup significantly reduces the internal dimensions of the
artery (vessel lumen), restricting blood flow as shown in Figure 1.1. Plaque is heterogeneous in
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nature, and is composed of fats, proteins, and regions of calcification separated by a thin layer
called the “fibrous cap”.

The streaked appearance of the histology clearly highlights the

heterogeneity of the plaque. This extreme heterogeneity coupled with the highly irregular shape
of the lumen makes it difficult to predict the mechanical behavior of the plaque as a response to
WSS and normal stresses (NS). In healthy arteries, there is evidence to suggest that the arterial
system remodels to maintain wall shear stress (WSS) within a narrow range of 1-2 Pa.

Figure 1.1. Cross-section through an atherosclerotic carotid artery.
Glickman, Selby et al. 2003).

Obtained from (Bale-

Consequently, the use of modeling stenosis severity or degree of constriction has evolved
as a surrogate to measure the risk of stroke. Mechanical properties of the arterial walls are
significantly altered by atherosclerosis. The interaction between flowing blood and the artery
wall is important in studying the development and progression of arterial disease and risk of
stroke (Ku, Giddens et al. 1985, Ku 1997). Since the ICA supplies blood to the brain, plaque
buildup in this branch of the CCA is generally considered to be more clinically relevant than that
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in the ECA. A magnetic resonance angiogram of a healthy and stenosed carotid bifurcation
artery is provided in Figure 1.2. The next section presents a discussion on the motivation of the
present study.

Figure 1.2. Magnetic resonance angiograms of (a) a healthy carotid bifurcation, (b) an
atherosclerotic carotid bifurcation. CCA-common carotid artery; ECA-external
carotid artery; ICA-internal carotid artery. Obtained from (Bale-Glickman, Selby
et al. 2003).

1.1 Motivation of the Present Study
Although there has been more than thirty years of cardiovascular research, the fluid
dynamics of arteries are still poorly misunderstood (Zhang, Agnoletti et al. 2014).

Fluid

dynamics is a subject of paramount importance due to the conventional relationship between the
hemodynamics, endothelial cell response, and vascular pathology (McDonald 1974; Fung 1993).
Physiological fluid flow is proclaimed to be laminar and organized.

In contrast, diseased

conditions are strongly coupled with transitional or turbulent flow, complex flow patterns, and

5
separating or stagnating flow. However, understanding and probing the fluid dynamics of
physiological systems in vivo is exceptionally challenging. Simplifications and idealizations are
necessary in order to study the flow phenomena under controlled in vitro experiments.
Nonetheless, even under these conditions the challenges are massive.

Complex flow patterns and fluid-structure interactions (FSI) emerge within short, curved,
branching, elastic tubes that undergo dynamic motions while interacting with propagating and
reflecting pressure waves (Pedley 2000). The pressure driven flow is considered to be transient,
transitional, anisotropic, and inhomogeneous, and is dependent on the frequency and phase of the
driving pressure. Entrance effects, unsteady separation, and formation of secondary vortices are
also prominent.

Comprehensive investigations of such complex flows are hindered by

limitations of current experimental and computational tools. Prediction of vascular disease or
design of effective prosthetic devices cannot be done without a fundamental understanding of the
physical phenomena that lead to pathological flow conditions.

A key example of fundamental deficiencies is the use of vascular stents, particularly in
coronary arteries, where flow dynamics are further complicated due to a flow and pressure phase
offset and dynamic curvature changes. Stents are a class of cardiovascular implants used to reopen arteries and re-new normalized blood flow. A stent is a cylindrical tube shaped medical
tool used for invasive therapy to treat stenosis that has developed inside a blood vessel resulting
from arteriosclerosis obliterans or other causes. The overall procedure is nominally invasive and
clinical studies indicate superior long term patency versus other methods. As a result, stents
have received widespread acceptance and emerged as the prevailing treatment for stenosed
arteries.
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Millions of stent implant procedures are performed each year. The use of stents has
dramatically increased since their approval by the United States Food and Drug Administration
in 1994, largely because of therapeutic and technological advances. In 1998 over 800,000 stents
were implanted in more than 500,000 patients in the United States (Topol 1998). Recent
advances in materials, fabrication procedures, and new drug coatings open possibilities for the
use of stents beyond treatment of stenosed arteries. For example, stents can be employed for
treatment of aneurysms or as vehicles for targeted drug delivery.

However, despite their

widespread use and numerous clinical studies, stents are implanted into arteries without a-priori
understanding of the associated fluid dynamics. The positioning of stent struts in the bifurcation
and the stresses generated in the stent and vessel wall are worthy of investigation for a better
understanding of the mechanical behavior of artery wall.

Few experimental investigations into the hemodynamics of stented arteries exist, due to
many reasons that made computational studies difficult (Duraiswamy, Schoephoerster et al.
2007; Lewis 2008; Charonko, Karri et al. 2010). Also, despite extensive previous work there is
practically no research on the effect that compliance variation and discontinuities have on the
hydrodynamics (Selvarasu, Tafti et al. 2011; Shuib, Hoskins et al. 2011). Moreover, although
healthy physiological flow is primarily laminar and organized, in contrast, diseased conditions,
namely inflammation, atherogenisis, or thrombus formation, are linked to complex and
transitional flow that is attributed to localized changes of the geometry and the mechanical
properties (McDonald 1974; Fung 1993; Batchelor 2002; Selvarasu, Tafti et al. 2011). One
difficulty for experimental studies is matching the physical scaling of the small coronary vessels,
as it is often difficult to create full dynamic similarity with a scaled-up model, and achieving

7
sufficient spatial resolution and accuracy at a 1:1 scale is challenging (Charonko, Karri et al.
2010).

Previous studies have overcome some difficulties in working with compliant models by
using dye visualization in large-scale models (Berry, Santamarina et al. 2000), or performing
quantitative measurements in idealized, scaled-up, rigid fixtures (Natarajan and MokhtarzadehDehghan 2000; Benard, Coisne et al. 2003). Many studies have used idealized velocity profiles,
and none took into account the effect of phase angle between the pressure and flow, which
occurs in the coronary arteries (Qiu and Tarbell 2000). Also, previous studies have been
subjected to several assumptions, simplifications, and limitations. Some studies have neglected
the effect of the stent deployment strategy and the post-stent injury causes to the artery that
would contribute to restenosis (Selvarasu, Tafti et al. 2011). The effect of changes in mechanical
stresses in the vessel wall might be important and affect vessel remodeling (Selvarasu, Tafti et al.
2011).

Although, this effect is compounded by the combined hemodynamic changes, and

literature suggesting that changes in hemodynamics would affect stenosis is extensive. Yet, if
and how compliance mismatch affects the local hemodynamics is unresolved. The next section
presents the ultimate goal and specific objectives of the present study.
1.2 Ultimate Goal and Specific Objectives
The challenges associated with resolving physiological flows include: understanding the
fundamental physics of physiological flows; understanding the source of disease processes and
their relation to fluid flow and transport processes; developing novel and improved disease
diagnostics, treatment methods and implantable devices; and developing biologically-inspired
systems and devices.

As a result, the ultimate goal of the present study is to aid in the
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development of tools to assist in the treatment of CVD and atherosclerosis.

Gaining an

understanding of hemodynamic parameters for medical implants allow clinicians to have some
patient-specific proposals for intervention planning. By enhancing technical knowledge in this
area of cardiovascular research, the present study incorporates experimental and computational
models which include supplementary “non-idealized” features and parameters than previous
studies have. The next section presents the specific objectives. The specific objectives are
denoted “Obj” and sub-objectives “Sub-obj”. The subtasks of each sub-objective are bulleted.

(Obj 1.) Develop an arterial cardiovascular experimental phantom to determine the effect of
orthostatic hypotension on hemodynamic parameters.
(Sub-Obj 1.) Design and fabricate a cardiovascular experimental phantom that contains
the aorta, major arteries, and the veins and capillaries mimicked with a resistor.


Design a pulse duplicator that can duplicate physiological conditions (pressure,
flow rate, frequency, and temperature).



Instrument the cardiovascular experimental phantom with pressure and flow
measuring devices.



Determine a test protocol for evaluating the cardiovascular phantom in transient
studies.



Obtain physiological data (flow rate, pressure, normal stress, wall shear stress,
and vorticity) during transition from bed-rest to upright position.



Determine the effect of physiological Peclet numbers on mass transport in the
phantom.
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(Sub Obj 2.) Develop and design a digital cardiovascular phantom for transient studies.


Obtain physiological data (flow rate, pressure, normal stress, wall shear stress,
and vorticity) during transition from bed-rest to upright position.



Determine the effect of physiological Peclet numbers on mass transport in the
phantom.

(Obj. 2.) Develop methods to model patient-specific arterial geometries to predict hemodynamic
forces on arterial grafts and implants.


Develop a code to import patient-specific CTA scans and create numerical arterial
core geometries.



Use particle imaging velocimetry (PIV) to analyze the flow field.



Determine the overall forces that act on implants.



Determine the effect of stent design on hemodynamic forces.

Chapter 2 provides a review of literature on past and current work in the area of
experimental and computational cardiovascular hemodynamics, stent technology, and drug
eluting stent analyses. Chapter 2 characterizes the gaps in knowledge of the review of literature.
Chapter 3 addresses the methods and materials of the present study. In Chapter 3, each of the
measuring tools and devices used in addition to calibration methods and computational
methodologies are addressed. Chapter 4 addresses the results of the present study. Chapter 5
provides a conclusion in addition to recommendations for future work.
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2 CHAPTER 2
Literature Review

Chapter 2 provides a review of literature on past and present work in the area of
cardiovascular disease and hemodynamics. Experimental and computational models that were
developed and used by several research groups to simulate the functional behavior of arteries
under normal and diseased conditions are discussed. The overall goal of experimental and
computational modeling is to develop patient-specific predictive models which aim to assist in
the improvement of: cardiovascular diagnosis, therapy planning and treatment of cardiovascular
diseases (Menasche 2010; Siebes and Ventikos 2010). However, the achievement of this goal is
underpinned by the characterization of the underlying physiological mechanisms derived from
solid mechanics and fluid mechanics.

The following sections outline the current state of

knowledge in the area of hemodynamics, both computational and experimental, and categorize
the questions left unanswered. The next section will provide an introduction of the pathogenesis
of atherosclerosis.
2.1 Cause and Pathogenesis of Atherosclerosis
Atherosclerosis is defined as a vascular system disease that hardens and narrows the
arteries. The disease typically does not become symptomatic until there has been significant
disease progression. The set phase for atherosclerosis is when the endothelium of a blood vessel
is damaged by hypertension, viral infection, diabetes mellitus, or other causes. Monocyctes
adhere to the damaged endothelium which results in penetration of endothelium layers and
transformation into macrophages. Macrophages and smooth muscle cells absorb cholesterol and
neutral fats from the blood and procure a foamy appearance. These are termed foam cells and
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are visible as a fatty streak on the blood vessel wall. Platelets also adhere to areas of the
damaged endothelium sites, de-granulate, and release platelet-derived growth factor (PDGF).
PDGF stimulates mitosis of smooth muscle which eventually leads to a mass of lipid, smooth
muscle, and macrophages called atheroma (atherosclerotic plaque). The muscular and elastic
tissue of the artery becomes increasingly replaced with scar tissue. When atheroma becomes
calcified, it becomes very dense plaque. Such plaque formation results in arterial rigidity termed
arteriosclerosis.
There are several surgical techniques that are used to treat atherosclerotic symptomatic
patients. However, these treatments require precise knowledge of the severity of the plaque
formation. Atherosclerotic plaque leads to secondary clinical events by any combination of the
following three mechanisms: (i) thrornbolytic occlusion at the site of the stenotic plaque (ii)
release of emboli that become lodged distally causing significant flow reduction, and (iii) chronic
reduction of blood flow due to hemodynamic significant stenosis. Stroke is the third leading
cause of death in North America (Gorelick 1995). Stroke is one conceivable secondary clinical
event caused by atherosclerosis.
A number of studies have estimated that up to 80% of al1 strokes could be prevented
through lifestyle changes (Gorelick 1995). An important step towards reducing stroke risk is to
improve the identifying process of individuals who are at risk.

Accurate diagnosis and

assessments of carotid atherosclerotic disease is paramount so that low-risk plaques and high-risk
plaques can be differentiated. Part of the vasculature that is of specific interest is the carotid
bifurcation because it has been identified as a significant site for generation of cerebral emboli.
While it is often difficult to determine the origin of an ischemic event retrospectively, it is
estimated that between 20% and 30% of all strokes (ICA) has a structure that is unique to the
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vasculature. It is now widely accepted that arterial geometry and hemodynamics influence the
initiation and progression of disease (Glagov, Zarins et al. 1988).
Regions of slow and recirculating blood flow are particularly susceptible to deposition of
atheroma (Oshinski, Ku et al. 1995). However, regions of high wall shear stress are associated
with rupture of vulnerable plaque (Slager, Wentzel et al. 2005). A robust correlation has been
revealed between the degree of lumen narrowing (due to plaque) of the ICA and risk of stroke.
Degree of lumen narrowing also correlates with optimal patient management, where
symptomatic patients with severe stenosis are best treated surgically while those with mild
stenosis are best managed by drug therapy. These results have placed renewed emphasis on the
development of clinical treatment techniques.
Estimates of stenosis severity can be made directly from measurements of lumen
geometry (Desouza, King et al. 1991; Smith, Rutt et al. 1996) or indirectly from measurements
of blood-flow within diseased arteries.

Verifying the precision and accuracy of clinical

techniques can be quite difficult since there is often no benchmark method in which comparisons
can be made. Because of these issues, objective evaluations of clinical techniques often include
in vitro experiments using vascular phantoms with realistic geometries.

The next section

presents a discussion on methods of treatment for atherosclerosis and arteriolosclerosis.

2.2 Survey of Treatment Methods for Atherosclerosis and Arteriolosclerosis
The first ground-breaking and still commonly used method of treating atherosclerosis is
coronary artery bypass surgery. In this treatment method, fragments of the great saphenous vein
of the leg or small arteries from the thoracic cavity are used to construct a diversion (bypass)
from the aorta to a point on a coronary artery beyond the obstruction. Balloon angioplasty is a

13
treatment technique in which a thin, flexible catheter is threaded into a coronary artery to the
point of obstruction. Afterward, a balloon tip is inflated to press the atheroma against the arterial
wall which opens up the lumen. The practicality of balloon angioplasty is limited to welllocalized atheroma.
An additional method is laser angioplasty, which consists of an illuminated catheter
which enables the surgeon to view the diseased interior of an artery on a monitor. A laser is then
used to vaporize atheromas and reopen the artery. These treatment methods are cheaper and less
risky than bypass surgery.

Conversely, there is particular concern that these methods of

treatment may procure new injuries to the arterial walls. As mentioned in Chapter 1, stents are
also used as a tool for arteriosclerosis treatment. Stents are implanted into the stenotic region of
interest (ROI) on a balloon catheter, typically after angioplasty. The stent is then expanded until
plastic deformation occurs, providing scaffolding-like features. The aim of the scaffolding
feature is to prevent arterial recoil.
Stents of two types are generally available: bare metal stents (BMS) and drug eluting
stents (DES). DES comprises of a pharmacologically active agent (medical treatment drug) that
is delivered to the targeted stent deployment ROI site and is intended to reduce the stenosis. In
several cases, the medical drug is integrated into and released from a polymeric coating (Parker,
Dave et al. 2010) of sufficient capacity to accommodate the selected dose and to modulate its
delivery to the ROI (Yang and Burt 2006; Wessely 2010). Provided that stents are extensively
used for treatment of coronary artery disease, they often induce adverse biological responses.
One response is reduction in lumen size as a result of formation of the neointima within the first
year of stent implant surgery. This process is termed restenosis. Another response is formation
of blood clots inside the vessel termed thrombosis (ST).
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Thrombosis and restenosis are the major drawbacks of coronary stent replacements
(Topol and Serruys 1998; Kastrati, Mehilli et al. 2001). Both restenosis and ST presents a major
issue and limitation of BMS, yet has been the advent of DES. Although all types of coronary
stents can be associated with ST, there has been recent specific concern in relation to the ongoing
risk of ST beyond six months after stent implanted surgery. As opposed to BMS, DES prolongs
the development of vessel repair including endothelialization, and can trigger a thromogenic
response leading to late thrombosis. Both these responses, restenosis and ST have been proposed
to be affected by altered hemodynamics inside the stented vessels. Percutaneous coronary
intervention (PCI) of atherosclerotic disease located in coronary bifurcations has always been
challenging, as a high restenosis rate persists even after implantation. Numerous experiments
have been performed on developing arterial stents (many of which involving animals), not to
mention the need for clinical trials before accreditation is finally granted.
The time period evolving from “a good stent design idea” to regulatory approval has led
to the question of whether numerical modeling could be used to optimize stent designs.
Undoubtedly, only those stents which show promising results in laboratory and clinical trials are
retained and those that do not are discarded after considerable investment. In the early years the
drug release mechanism was very poorly understood, but through mathematical modeling
approaches, combined with experiments, researchers have helped identify the dominant
mechanisms of release in a number of stents.

While release experiments alone can give

information regarding the release profile and the duration of release, the data generated is for one
particular set of parameters (e.g. coating thickness, drug type and concentration) and the
experiment needs to be repeated for each parameter measured. Once substantiated, numerical
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models have the advantage of allowing several parameters to be varied and the release profiles
compared without the need to repeat the experiments.
The ability of a numerical model to help identify the important parameters that govern the
drug release is instrumental. Numerical modeling can also play an important role when an
understanding of the drug distribution within arterial tissue is required. Cardiologists have often
stressed that uniform drug concentrations across the wall are desired, and that these
concentrations should be maintained within some minimum therapeutic and toxic levels.
Obtaining this kind of information from experiments is extremely challenging, yet free and
bound drug concentration profiles can readily be output from a mathematical model. However,
experiments and numerical modeling must go hand in hand. The accuracy of the model results
can only ever be as good as the quality of the inputs, especially when the model is sensitive to
changes in one or more of the parameters.
The accurate determination of system parameters remains one of the biggest challenges in
the field due to the natural variation between species and the complexity involved in making the
required measurements, especially in the in vivo situation. However, some recent progress has
been made by combining in vitro/ex vivo experiments with simple numerical models, and this
approach may continue to yield useful results in the future. Conclusions which can be drawn
from modeling have provided useful insights, some of which are counter-intuitive. Among the
many other benefits of adopting a modeling approach include the potential to indicate at an early
stage the designs that are doomed to failure, to design stents that are optimized and to result in a
reduction in the number of experiments required. The next section provides a comprehensive
review of the modeling of drug-release from arterial stents and the subsequent arterial drug
redistribution.
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2.3 Numerical Modeling of Drug Release from Arterial Stents
A vital aspect in the performance of any DES is the drug concentration/release profile. If
too much drug is delivered then toxicity can arise, whereas if too little drug is delivered then it
may have no effect at all. Of course, this „„therapeutic window‟‟ varies between drugs and
between patients and after implantation. Stent manufacturers routinely test the release of drug
from their stents in an in vitro environment to gain an understanding of the shape of the release
profile and to compare the release profile of different devices. This allows the manufacturers to
determine the repeatability of the release profile. Whereas the in vitro release is unlikely to
replicate the in vivo situation, it is nonetheless an important step in the development process.
From the modeling perspective it makes sense to start with simple models, and in particular, it
seems sensible to firstly consider modeling release in a controlled in vitro environment before
embarking on the highly complex in vivo situation.
A number of authors have focused specifically on modeling the release of drugs from
DESs, electing to put to one side the range of complexities that are observed in the in vivo
situation (including flowing blood, pulsatile nature of flow, wound healing, proliferation,
migration of cells and complex uptake/binding). This approach has proven to be useful in
helping to address the question of which mechanisms are behind the release of drug from a
number of stent systems and also in allowing estimates of parameter values (e.g. diffusion
coefficients) to be made. However, modeling drug release is not an area of research exclusive to
DESs. In fact, scientists have been devising models which describe the release of drug from
tablet formulations and drug delivery devices for decades. It is therefore not a surprise that the
early models of drug release from DESs incorporated well-established ideas from other
applications.
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Newer generation DESs which have focused on biodegradable polymers and polymerfree modified surface designs are likely to have more complicated mechanisms of release, and so
it is of industrial relevance to consider these types of stents in their own right. In the case of
stents with biodegradable polymeric coatings, the drug release may involve diffusion, erosion
and possibly dissolution and/or swelling (Siepmann and Siepmann 2008) and (Fredenberg,
Wahlgren et al. 2011). However, in the case of polymer-free stents, it is less clear how the
sustained release is obtained and how this may be modeled. Because of the complexities
involved in systems which degrade as they release drug, a model which is shown to be accurate
for one system may be useless for another. Table 2.1 provides an overview of DES literature.
Newer generation DESs which have focused on biodegradable polymers and polymerfree modified surface designs are likely to have more complicated mechanisms of release, and so
it is of industrial relevance to consider these types of stents in their own right. In the case of
stents with biodegradable polymeric coatings, the release of the drug may involve diffusion,
erosion and possibly dissolution and/or swelling. Some of the common processes which appear
in these models include: hydration, degradation and erosion. Hydration is simply the process of
combining with water. Degradation is a chain scission process which involves the breaking of
polymeric chains by free radicals. On the other hand, erosion is material loss from a system and
can be either surface erosion or bulk erosion. With surface erosion, water intrusion into the
polymer is slow compared with the rate of degradation, thus the polymer is „eaten away‟ from
the outside to the inside. With bulk erosion, the rate of degradation is slow compared with the
rate of water uptake and so the entire system is rapidly hydrated and degradation occurs
throughout the whole material equally.
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Table 2.1
Survey of Drug Eluting Stent Computational Studies.
Author

(X. Zhu 2014)

(Zhu, Pack et al. 2014)

(M. Horner. 2010)

Study

Parameters

Conclusion

Recommendations

This work presents
a
model
that
describes
the
integrated process
of drug release in
PLGA coating and
subsequent
drug
delivery in
the
arterial wall.

Bound, internalized,
and free drug
concentration and strut
embedment

The developed model
here provides the basis
for evaluating and
studying a PLGA
coating
for
stent
applications,
with the ease of
adaptation to more
sophisticated scenarios
(e.g., consideration of
more
pathological
conditions).

Factors related to the
pathological conditions;
such as plaque, thrombus,
and regions of tissue
compression should be
considered
in
future
work.

This
paper
mathematically
models
the
integrated process
of (1) the delivery
of a hydrophobic
drug from a drugeluting stent with
biodurable
polymeric coating
and
(2)
drug
distribution in
the arterial wall
with
reversible
binding.

Free and bound drug

Drug release from
an implanted drugeluting
stent
is
affected by the
surrounding
arterial
wall via the vascular
drug diffusivity
and reversible binding
reaction,
which
implies a
potentially
large
difference from in
vitro release
behaviours
of
a
hydrophobic drug.

Future studies should
incorporate
design
optimization studies with
reversible
reacting
mechanisms.

The main goal of
this study was to
combine a realistic
geometry for the
deployed stent and
vessel wall with a
newly
proposed
two-species
computational
model for drug
transport.

Free and bound drug

The model was shown
to exhibit the correct
behavior when drug
binding
affinity,
diffusivity, and wall
plasma
convection
were
varied.
Therefore, the model
is useful for studying
the effect of drug
physicochemical
properties and local
transport factors on
drug distribution and
retention in the vessel
wall.

Future directions for this
work include modeling
the coating and finite
drug
reservoir,
the
presence of thrombus, or
allowing for neighboring
or overlapping stents. The
latter might require the
inclusion of luminal
flow in the model to
achieve
the
correct
delivery patterns

Prabhu and Hossainy (2007) focused specifically on the degradation and release of
everolimus from a polylactic (PLA) stent coating and validated their compartmentalized model
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using in vitro data. The model considers two non-linear reactions: the hydrolysis (by water
intrusion) of PLA to produce oligomers and lactic acid and the hydrolysis of oligomers to
produce lactic acid. Five reaction diffusion equations are presented to describe the temporal and
spatial evolution of the concentrations of water, PLA, oligomers, lactic acid and everolimus. The
model equations were solved using an iterative finite difference approach which updates
estimates of the various parameters via comparison with the experimental data. The authors
indicate that autocatalysis (i.e. a reaction where the reaction product itself is the catalyst of the
reaction) is important and cannot be ignored. While not directly focusing on DESs, (Siepmann
and Gopferich 2001) provided a review of the mathematical modeling of bioerodible polymeric
drug delivery devices. The authors considered only systems where the drugs are physically
immobilized within a water insoluble polymeric matrix. The authors stressed that accurate
physiochemical characterization of the investigated system is an absolute pre-requisite for the
appropriate mathematical modeling of the device, and as such they detail techniques to
experimentally characterize degradation and erosion.

These can help identify whether the

erosion is surface or bulk and assist in clarifying the time-dependence of the diffusion
coefficients.
The model used in the study of (Lee 1980) lends itself to an approximate analytical
solution for drug release from thin eroding films and the models of (Joshi and Himmelstein
1991) which accounts for acid producing species that accelerate matrix hydrolysis. The authors
comment that modeling efforts should try to take into account the in vivo conditions since, for
example, cellular tissue reactions can affect the degradation process. Again, not referring
specifically to DESs, (Rothstein, Federspiel et al. 2009) present a unified model for the
prediction of controlled release from surface and bulk eroding polymer matrices which also
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accounts for the transition from surface eroding to bulk eroding behaviour during the course of
degradation. The study of (Soares and Zunino 2010) introduced a mixture model for water
uptake, degradation, erosion and drug release from polydisperse polymeric networks. Each
constituent of the model represents chains of an average size. A multiscale description of
degradation and erosion is proposed, combining the molecular description of scission with Fick‟s
macroscopic laws of diffusion. The approach adopted here describes degradation by means of
the time evolution of weight fractions of polymeric constituents of average degree of
polymerization. The authors argue that the key advantage of their model is the fact that polymer
degradation is described as an individual chemical reaction.
In the study of (Baran, Ogino et al. 1997), a bioresorbable DES model based on detailed
constitutive equations and taking into account the main physical and chemical mechanisms
involved in coating degradation, drug release and restenosis inhibition was used. Their results
were verified against selected in vitro and in vivo data available in the literature. In the study
of (Hill 1983), the authors considered a two dimensional dissolution–diffusion model which also
included surface erosion. In the study of (Korakianitis and Shi 2006), the authors reported that
the drug may exist in the coating in a form which needs to dissolve before it can diffuse. The
authors considered the drug in polymer as two separate phases: a dissolved phase and a solid
phase with concentrations CfCf and CbCb, respectively. Only dissolved drug is allowed to
diffuse. The authors included a source term in the diffusion equation to account for the solid
phase dissolution.

The next section presents a review of literature on modeling the drug

transport in the arterial wall.
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2.4 Survey of Numerical Drug Eluting Stent Studies
Modeling the release of drug from arterial stents is only a one part of the story. What
happens to the drug after it is released in vivo is of more clinical interest and certainly more
difficult to model. Clinicians advise that a uniform drug concentration should be attained across
the arterial wall, and the concentration should be maintained within some therapeutic window.
Thus an understanding of the structure and components of the arterial wall is crucial. The
arterial wall is a porous heterogeneous structure, consisting of three distinct layers. Closest to the
lumen is the intima, followed by the media and finally the adventitia (Panerai 1980).
The intima consists of the sub-endothelial space and the endothelial layer of cells, known
as the endothelium. This layer is crucial to the control of the normal function of the artery,
through its mediation of relaxation and contraction and via its control of smooth muscle cell
proliferation within the underlying media layer. The internal elastic lamina forms the outermost
part of the intima. The media region comprises smooth muscle cells, collagen and elastin.
Finally, the outermost layer of the arterial wall is the adventitia. The adventitia tethers the artery
to perivascular tissue, and contains cells known as fibroblasts as well as a network of small blood
vessels, called vasa vasorum, which act as a blood supply to the adventitia and provide a
clearance mechanism for drugs released into the artery wall.
2.5 Survey of Current Bifurcation Stent Implant Issues
The introduction of polymer-based anti-flammatory and anti-proliferative drugs released
in a controlled manner from coronary stents has changed the treatment results of PCI
considerably.

However, patients with certain multifaceted lesions have consistently been

excluded from most trials undoubtedly because of the combined distress of problems with
obtaining a high procedural success rate and of the difficulties in interpreting the angiographic
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and clinical results. Coronary bifurcations are periodically encountered and roughly 15-20% of
percutaneous coronary interventions (PCI) are implemented to treat bifurcations (Latib, Colombo
et al. 2009). PCI for bifurcation disease has been deliberated as a technically challenging
procedure. PCI has also been associated with lower procedural success rates and inferior clinical
outcomes than bifurcation lesions. Furthermore, there has also been enormous uncertainty and
debate as to the most appropriate treatment strategy when dealing with bifurcations. However, in
recent years noteworthy improvements have occurred in the overall understanding and treatment
of bifurcation lesions.
Initially, the introduction of DES have meaningfully reduced restenosis and repeat
revascularization rates demonstrated in both archive studies and a sub-analysis of the randomized
SCANDSTENT trail (Steigen, Maeng et al. 2006; Thuesen, Kelbaek et al. 2006).
SCANDSTENT was a randomized, controlled study that showed the beneficial effect of drugeluting stents compared with bare-metal stents in a large series of entirely complex coronary
artery lesions. The superiority of the sirolimus-eluting stent was evident in all subgroups of
patients, and among patients who had received the drug-eluting stent, target lesion
revascularization was only necessary in those with bifurcation lesions.
Early results using balloon angioplasty alone to treat bifurcation lesions demonstrated
relatively low angiographic and clinical success rates and high restenosis (George 1986).
Although the introduction of coronary stents resulted in more predictable results and higher
success rates, angiographic restenosis rates remain high, despite the use of different approaches
(Lefevre, Louvard et al. 2000; Sheiban, Albiero et al. 2000; Yamashita, Nishida et al. 2000;
Karvouni, Di Mario et al. 2001). Additionally, a more selective usage of two stents as intention
to treat has been implemented. Also, the acceptance of a suboptimal result in the side branch
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(SB) due to the fact that many residual stenosis at the SB may not be physiologically significant.
Fourthly, the better performance of two stent techniques associated with high pressure post
dilatation, kissing inflation and possible intravascular ultrasound; and finally the publication of
numerous trails specifically in bifurcations.
Consequently, these changes and outcomes after bifurcation PCI have improved
considerably and in some studies approximate those of non-bifurcation PCI. There have recently
been randomized trails and a large archive comparing provisional strategy of main branch (MB)
stenting with 1 DES vs. a 2 DES strategy of stenting both branches. From these reports, it is
evident that the percutaneous treatment of coronary bifurcation has progressed in a manner that
one stent vs. two stent appears to have been resolved. The provisional approach of implanting
one stent on the MB is now considered the default approach in most bifurcation lesions. This
approach is mainly due to the fact that routine implantation of two stents does not give superior
results compared to selective usage.
Despite the simplicity of the provisional approach, this technique frequently leaves the
SB with a significant residual stenosis (most trials evaluating the provisional approach quote
success as 30% residual on the MB and less than 50% residual on SB). The results follow
implantation of two stents is sometimes suboptimal and therefore the follow up is inferior to
expected. Operator experience, willingness to devote sufficient time and effort to optimize the
result (especially on the SB) and usage of intravascular ultrasound elements frequently needed
when implanting two stents.

In the work of (Latib, Colombo et al. 2009), the authors

experienced a stricter adherence to this approach and the results have contributed to the
improvement seen over the last few years following implantation of two stents in bifurcation
lesions. However, the introduction and perfection of dedicated bifurcation stents may simplify
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this task and change the current proposed approach to bifurcation treatment. Presently routing
stenting of both branches appears to offer no advantage over a provisional approach. A more
detailed overview can be found in (Colombo, Moses et al. 2004). The next section presents a
discussion on fluid-structure interaction of arteries.
2.6 Survey of Computation Arterial Hemodynamic Studies
In the efforts to analyze the cardiovascular system and effects of diseases on it different
ways of analyzing hemodynamic parameters are practical such as lumped model, one, two or
three dimensional modeling and experimental methods. In this section lumped, one, two and
three dimensional models are discussed.

Lumped models (zero dimensional) and one

dimensional models are electrical circuitry models that provide only time dependent data for
hemodynamic studies. Electrical components used in the electrical circuit are used as a surrogate
for fluid parameters. A review of lumped and one dimensional studies are provided in Table 2.2.
The use of mathematical models in the simulation of cardiac dynamics plays a vital role
in understanding cardiac physiology and pathology and possible treatment techniques. Early
studies were performed to understand and simulate healthy cardiac dynamics at the physiological
scale (Arai, Alpert et al. 1993) or to describe cardiac contraction (Aroney, Herrmann et al. 1989).
For example, researchers have developed several time varying elastic models for modeling the
ventricular at the organ level.

Mathematical functions took over the role to initiate the

simulation of the hemodynamics at the organ level (Arts, Bovendeerd et al. 1991; Beuckelmann,
Nabauer et al. 1992; Beltrami, Finato et al. 1994; Atar, Gao et al. 1995). In these models, the
activation function was defined using trigonometric, polynomial or exponential functions. In
time varying elastic models, only blood pressure and volume can be simulated.
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Table 2.2
Survey on One Dimensional Cardiovascular modeling techniques.
Application

Model Feature

Ventricular assist device support
for heart failure

The native cardiovascular system was in
heart failure condition, and a VAD model is
coupled

Study of cardiovascular response
under neuro-regulation

As boundary condition in
multi-scales simulation of
cardiovascular dynamics
.

The native cardiovascular system was
coupled with the models for the
nervous system

The 0-D circulation system model was
coupled with the distributed parameter
models (1D, 2D or 3D).

Studies
1.

Studies of cardiovascular response in the heart
condition of VADs (Voitl 2009)

2.

Studies of cardiovascular response in the heart
failure condition support with intra aortic
balloon pumps

3.

Comparison of the assistance action of different
types of VAD and VAD motion profiles.

4.

Study of the effect of the inlet and outlet
cannulation sites for connecting the VADs to the
native cardiovascular system. (Shi, Korakianitis
et al. 2007)

5.

Study of the physiological control of pulsatility
gradient in rotary blood pump (BhattacharyaGhosh, Bozkurt et al. 2014)

1.

Simulate the cardiovascular responses under
neuro-regulation in various conditions of
isocapnic hypoxia hypercapnia and hypocapnic
hypoxia (Ursino and Magosso 2000; Shi,
Lawford et al. 2011) carotid occlusion (Aquino,
Robinson et al. 2014)

2.

Simulation of cardiopulmonary response in
Valsalva manoeuvre (Lu, Clark et al. 2001;
Aboamer, Azar et al. 2014)

3.

Simulation of the cardiovascular response to
orthostatic stress (Shaw, Loughin et al. 2014)

1.

Multi-scale simulation of the cardiovascular
dynamics (Formaggia L. Et al 1999; Pontrelli G.
2004)

However, in a failing heart a number of changes occur due to pathophysiologic mechanisms at
different levels of biological organization.
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Some models have attempted to understand the underlying mechanisms of contraction by
increasing the level of complexity of mathematical models used to describe them, via the
addition of relevant processes at different biological scales.

For example in the study of

(Hossainy and Prabhu 2008), the authors described the relationship between left ventricular
pressure and volume, as well as systolic fiber stress and strain in the wall (Hossainy and Prabhu
2008) driven by an activation function to simulate the hemodynamics over a cardiac cycle. This
model simulates the contraction of a single fiber at microstructural level, and extends this to a
complete ellipsoid ventricle at microscopic level assuming homogeneous distribution and
function of all muscle fibers, thus rendering ventricular hemodynamics. (Cox, Loerakker et al.
2009) used this model to describe the right ventricular hemodynamics in a healthy and
pathological configuration by modifying the wall volume and zero pressure volume in the left
ventricle (Cox, Loerakker et al. 2009).

Diaz-Zuccarini and LeFevre (2007) modelled the

contraction of a sarcomere and defined the ventricle as a cylinder. Also here, the ventricular
dynamics were obtained with the assumption of a uniform sarcomere distribution in the ventricle.
Other models focus on cardiac cells and include the generation of the action potential.
For example, the Luo–Rudy model (Luo and Rudy 1994) is widely used in electrophysiological
literature to describe the ion fluxes and channel currents of a ventricular myocyte resulting in the
transmembrane (action) potential.

The numerical reconstruction of the ventricular action

potential is based on a Hodgkin–Huxley type approach (Luo and Rudy 1994). An advanced
model of the Luo–Rudy model is given by Livshitz and Rudy (Livshitz and Rudy 2009)
accounting for the ion channel kinetics, calcium handling, and dynamic changes in the
intracellular/extracellular milieu during the action potential. To consider the relevance of
intracellular calcium dynamics during the excitation contraction coupling process (ECCP) of a
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myocyte, the sliding filament model (SFM) (Rhodes, Ropella et al. 2003) describes its
interaction and sensitivity with myofilaments within a sarcomere at the protein level.
The cardiac cell models mentioned above have been used to simulate physiological and
clinical situations. However, these models do not take into account the connection between
different biological scales, which is crucial for understanding cardiac physiology as a holistic
process.

Various approaches have been undertaken to understand the coupling between

microscopic and macroscopic elements of the cardiac contraction and its physical mechanisms
using mathematical models. Bhattacharya-Ghosh et al. presented a blueprint for a multi-scale
model of the ventricle (Bhattacharya-Ghosh, Schievano et al. 2012). This model describes
events in which relevant mechanisms are mathematically described and coupled at the protein,
cellular and organ scales in order to provide a better understanding of the combined ECCP as a
whole. However, this model does not incorporate the four heart compartments and circulatory
loop.
A three-parametric model of heart muscle behaviors was introduced (Zacek 1996) and a
modification of this model was presented later (Rideout 1991). It successfully predicted force
development during a time period of heart, showing deactivation of the contractile element
during isotonic shortening and the apparent dependence of series stiffness in time. The study of
the series elasticity of cardiac muscle was presented (Rupnic 2002). Afterwards, the timevarying elastic model of the left ventricle was introduced and later the relationship between
pressure-volume area and cardiac oxygen consumption was described (Helde 2002). Finite
element methods are commonly used to simulate the left ventricular way of operation. The first
computer models describing the arterial system were presented in the sixties. The authors
constructed a multi-branched model of the systemic arterial tree in a form usable for digital
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computer, which allowed simulation of different physiological and pathological conditions. This
model was extended in detail later (Wang 2004). Also, blood flow through site of particular
interest of the arterial tree such as anastomoses, stenoses and bifurcations can be described with
finite element method simulation. The mathematical analysis of the whole human cardiovascular
system remains as a complicated task and for that reason models are simplified with respect to
particular parts of interest.
There is no single mechanism that can account for atherogenesis, other than being
interpreted as the complex interaction of many processes (Van Wyk, Wittberg et al. 2014).
Different slow acting biochemical and mechanical processes have been linked to the initiation or
progression of the disease. The most recent sets of hypotheses relate low time-averaged and
oscillatory wall shear stress (WSS) to regions prone to disease (Bharadvaj, Mabon et al. 1982;
Bharadvaj, Mabon et al. 1982; Zarins, Giddens et al. 1983; Ku, Giddens et al. 1985; Gambillara,
Montorzi et al. 2005). These fluid mechanical aspects are thought to increase residence times
favorable to near wall biochemical processes and transport mechanisms of atherogenic materials
towards these near wall sites (Bharadvaj, Mabon et al. 1982; Bao, Lu et al. 1999). Other studies
suggest that high WSSGs lead to cell dis-orientation in the endothelial layer (DePaola, Davies et
al. 1999; Nagel, Resnick et al. 1999; Farmakis, Soulis et al. 2004) or intimal hyperplasia that are
regarded as possible initiators to atherogenesis (Depaola, Gimbrone et al. 1992; Haidekker,
White et al. 2001; White, Haidekker et al. 2001). The analysis of each of these hypotheses is
compounded by the pulsatile nature of blood flow and the consequentially large spatial flow
variations in time.
computational studies.

Table 2.3 presents a notable review of recent arterial hemodynamic
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Table 2.3
Review of Arterial Hemodynamic Computational Studies.
Authors

Study

Parameters

Conclusion

Recommendations

(Xiang, Siddiqui et al.
2014)

The objective of this
study was to examine
the
sensitivity
of
widely
used
hemodynamic factors
derived from CFD to
different
inlet
waveforms under the
same inflow rate.

This study specifically
focus on WSS and
OSI,
the
two
independent
parameters predictive
of rupture in our
multivariate
logistic
regression model

The authors stress that
patient-specific flow
boundary conditions
are highly desired for
image-based
CFD
simulations. However,
only a few CFD
studies have them

For studies of large
cohorts aiming at
finding
statistical
correlations between
aneurysm rupture and
hemodynamics,
we
may have to use nonpatient-specific
inlet
boundary conditions in
the current situation.

(Xiang, Tutino et al.
2014)

In Part 1 of this 2-part
review, a hypothesis is
proposed
which
includes:
both high
and low wall shear
stress drive intracranial
aneurysm growth and
rupture through mural
cell mediated and
inflammatory
cell
mediated destructive
remodeling pathways,
respectively. Part 2,
delineates
different
wall
shear
stress
parameter definitions
and survey recent
computational
fluid
dynamics studies.

Wall shear stress

Computational
fluid
dynamics
findings
correlating both high
and low wall shear
stress with intracranial
aneurysm growth and
rupture
puzzle
researchers
and
clinicians alike. These
conflicting
findings
may
stem
from
inconsistent parameter
definitions,
small
datasets, and intrinsic
complexities
in
intracranial aneurysm
growth and rupture.

Refinements
are
needed which will
yield more accurate
predictive models for
intracranial aneurysm
risk assessment from
computational
fluid
dynamics

(Qiu, Fei et al. 2013)

This paper studies the
influence of a HighPorosity Mesh (HPM)
stent
on
the
hemodynamic
characteristics in the
intracranial aneurysm
based
on
the
Computational Fluid
Dynamics (CFD). An
idealized basilar tip
aneurysm model and a
HPM stent model was
built.

Wall shear stress

The
following
conclusions can be
drawn: when applying
the stent to treat the
aneurysm, the wires of
the stent impede the
blood flow into the
aneurysm sac, which
would
significantly
reduce the magnitude
of the impact force of
the blood flow, the
pressure and the WSS
at the dome of the
aneurysm wall.
dynamic behaviors of
blood through the
patient-specific carotid
bifurcation
arterial
geometries based on
numerical approaches
showed
differences
when compared to a
simplified model

Future results should
not only provide a
valuable reference for
optimizing the stent
design, but also help
neurosurgeons to select
suitable stents and to
establish
reasonable
operation procedures.

(Hewlin and Kizito
2011)

Wall Shear stress,
Normal Stress, and
vorticity

Future studies should
incorporate
more
realistic
boundary
conditions
obtained
from experimental data
from flow phantoms or
as an alternate blood
flow rate obtained.
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In order to study these hypotheses several experimental and numerical investigations
implement various mean WSS based indicators to simplify the analysis of the temporal WSS
variations in identifying atherosclerotic prone locations (Zarins, Giddens et al. 1983; Ku,
Giddens et al. 1985; Pedersen, Oyre et al. 1999; Lei, Giddens et al. 2001; Soulis, Giannoglou et
al. 2007). These indicators include the time averaged WSS (TAWSS), oscillatory shear index
(OSI) and relative residence time (RRT). In the quoted studies indicators are usually shown to
be well correlated with plaque affected regions, however also possibly in agreement with unaffected regions. The application and usefulness of these indicators in more complex arterial
junctions is therefore not well understood.

2.7 Survey of Flow Phantoms and Measurement Techniques
Flow phantoms are a vital tool for studying hemodynamics of arteries using Doppler
Ultrasound (DS) and Particle Image Velocimetry (PIV). In the production of realistic flow
conditions, it is highly desirable to be able to produce arbitrary geometries, including branching
stenosis, that closely mimic in vivo geometries. Usually, wall-less vessels have been employed
to avoid mismatch problems in acoustic properties (Patterson and Foster 1983; Rickey, Picot et
al. 1995; Guo and Fenster 1996), and to produce more complicated geometries by using a lost
material casting technique (Poepping et al. 2002; Smith et al. 1999).

Conversely, with

employing wall-less vessels, the tissue-mimicking material (TMM) may be susceptible to
changes due to exposure to air or water (Hoskins and Tamanarine 2000), incompatibilities with
the blood-mimicking fluid (BMF) or breakage and leakage problems, as addressed by
(Ramnarine, Anderson et al. 2001). Therefore, it is also desirable to have a completely sealed
phantom, where the agar-based TMM is sealed from air or fluid exposure.
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A number of flow phantoms are reported in the literature and have been reviewed by
(Hoskins 1997). However, most of the flow phantoms previously developed have consisted of a
simple geometry, such as straight tubes, or a stenosed geometry formed by shrinking tubes,
inserting tapers or extracting rods. The development or more realistic phantom geometries has
been primarily limited by the lack of versatile vessel-mimicking materials (VMMs). A major
consideration for the development of a new VMM was the ability to fabricate a robust flow
phantom, with vessels of anatomically accurate models, which can withstand physiological flow
stresses. Key design considerations include robustness, stability, elasticity, wall thickness, speed
of sound, acoustic attenuation, echogenicity and, finally, practical considerations for fabrication,
such as versatility, variations in echogenicity and the incorporation of plaques or irregular
surfaces.
Additionally, the main physiological features to be included are the wall thickness and
elasticity. It is necessary to match the wall thickness for realistic imaging and to match the
elasticity because of its contribution to the damping and propagation of the pulsatile waveform
during flow. Studies have shown that the wall thickness of the carotid arteries is approximately
0.65 to 0.95 mm, depending on gender, race and duration of diabetes (Riley, Barnes et al. 1992;
Folsom, Eckfeldt et al. 1994; BonithonKopp, Touboul et al. 1996; Wagenknecht, Dagostino et al.
1997). Also, arterial walls have been shown to have a nonlinear elastic behavior (Roach and
Burton 1957), due to the different elasticities of the elastin and collagen components. The
Young‟s elastic modulus of elastcity, 0.3 MPa is much lower than that for collagen, 300 to 2500
MPa (Dobrin 1978), and the resulting arterial elasticity is similar to elastin for normal
physiological strains, and approaches that of collagen for much higher strains. The incremental
Young‟s elastic modulus in the circumferential direction has been found, in normal human
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abdominal aorta sections, to range from approximately 0.04 to 2 MPa for corresponding
transmural pressures of 0 to 90 mmHg (0 to 12 kPa) (Drangova, Holdsworth et al. 1993) and, in
the human iliac artery, to range from approximately 0.05 to 1.45 MPa for transmural pressures of
0 to 120 mmHg (0 to 16 kPa) (Ryan and Foster 1997).
The critical acoustic properties to be matched are the speed of sound (SoS) and the
acoustic attenuation. Preferably, a VMM should be acoustically well matched to both the BMF
and the TMM. A disparity in the speed of sound between the VMM and surrounding material
(BMF or TMM) will produce reflection and refraction of the US beam, which can result in
distortion of the Doppler spectrum (Thompson, Aldis et al. 1990). Few suitable materials have
been found that match both the acoustic attenuation and the SoS of soft tissue (0.5 to 0.7 dB/cm
MHz and 1540 m/s, respectively). Many materials have been investigated and described for use
as the VMM in flow phantoms, as seen in the review by (Law, Johnston et al. 1989). C-flex
(Cole-Parmer, Vernon Hills, NY) is one popular choice for a VMM, with a speed of sound (1553
m/s) similar to that of tissue, but with a much higher attenuation (28 dB/cm at 5 MHz) that varies
with frequency to the power of 1.8 (Ramnarine, Anderson et al. 2001). Unfortunately, most of
the materials suggested as a VMM are generally available only as ready-made tubing, such as Cflex and latex, and are, thus, limited to straight-tube or stenosed-tube geometries with a
manufacturer- specified wall thickness and fixed echogenicity.
Silicone allows the opportunity to produce vessels with arbitrary wall thickness and
lumen geometry, due to its availability in a liquid form that can be cast to form a flexible
transparent elastomer. These elastomers are strong, yet compliant, chemically stable over time,
and do not absorb a significant amount of water (unlike latex rubber). Silicone has been used
previously to create tubes of various thicknesses for wave propagation experiments (Pythoud,

33
Stergiopulos et al. 1994), stenosed tubes for laser visualization and branched vessel models for
flow visualization (Melbin, Gopalakrishnan et al. 1982), by painting layers of an elastomer
(Sylgard 184) onto a rod or cast. A casting technique has also been used with this material to
produce a branched carotid model for use with laser Doppler velocimetry and flow visualization
(Cao and Rittgers 1998; Secomski, Nowicki et al. 2003). In what follows, the fabrication of a
sealed, US compatible, flow test object that consists of a thin-walled silicone-elastomer vessel of
arbitrary geometry embedded in a TMM is discussed.
Doppler methods are extensively used to quantify and visualize blood velocity in clinical
practice. Typically the maximum velocity waveform is used to quantify the degree of lumen
reduction in stenosed arteries, and indices based on the maximum velocity are used to quantify
the shape of the waveform. Further quantification has been used in research, studies such as the
measurement of velocity profile and volumetric flow (Picot and Embree 1994; Bohs, Friemel et
al. 1995; Picot, Fruitman et al. 1995), wall shear rate (Brands, Hoeks et al. 1995; Forsberg,
Morvay et al. 2000) and turbulence intensity (Poepping, Nikolov et al. 2002; Thorne, Poepping
et al. 2008). The process of measurement of velocity and related quantities using ultrasound is
complex and prone to error (Blake, Easson et al. 2009). Maximum velocity errors using spectral
Doppler in clinical ultrasound systems have been reported in the range of 0-100% (Hoskins
1997). The maximum Doppler shift arises from one edge of the Doppler aperture, whereas angle
correction is performed with respect to the center of the aperture (Hoskins and McDicken 1991)
Several CFD studies have examined flow through stenosed arteries. However, these
studies normally depend on turbulence models that agree poorly with published experimental
values. (Blake, Easson et al. 2009) reported that direct numeric simulation (DNS) of turbulence
would appear to offer a solution, but studies are phenomenally computationally intensive, which
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restricts their applications. While conventional CFD (i.e., non-DNS CFD) have been used to
investigate flow in complex geometries, the geometry becomes more complex and the agreement
between the CFD and experimental data is poorer. This discrepancy arises such that it is not
understood whether it is the CFD or the experimental technique that is at fault or both. This
situation outlines the need for validation methods based on experimentally measured data.
Previous experimental studies have used stenosis models to investigate the variation of
measured velocity with degree of stenosis (Hoskins 1997; Poepping, Nikolov et al. 2002; Steel,
Ramnarine et al. 2003). Generally, these studies contemplate the variation of estimated peak
velocity with machine settings and with the degree of stenosis. (Bascom, Johnston et al. 1997)
compared measured velocity using DUS with flow field visualization data measured using a
photochromic technique. Both the ultrasound technique and the photochromic technique used
either the same acrylic stenosis model or geometrically identical models. However, it is known
that acrylic has a high speed of sound more than 2500 m/s (Hoskins 2008), which leads to
distortion of the Doppler beam. In general, materials such as glass and Perspex, which are
suitable for optically-based flow studies have very high values of the speed of sound and are
unsuitable for use in ultrasound phantoms, which require materials whose speed of sound is
closer to 1540 m/s.
(Blake, Meagher et al. 2008) developed a technique to estimate the wall shear rate in
healthy arteries using a clinical ultrasound scanner. The method used a theory of fully developed
oscillatory flow together with a spectral Doppler trace and an estimate of mean arterial diameter.
A method using color of flow imaging was compared with the spectral Doppler method in
vascular phantoms and was found to have errors that were on average 35% greater. Differences
from the theoretic value for the time averaged wall shear rate using the spectral Doppler method
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varied by artery: brachial 9%, carotid 7%, femoral 22%, and fetal aorta 17%. Test measurements
obtained from one healthy volunteer demonstrated the feasibility of the techniques in vivo.
Blake, Meagher et al. 2008) used walled vascular phantoms with different lumen
diameters to mimic the physiologic conditions for a range of arteries. The vascular phantoms
were constructed from acoustically equivalent tissue-mimicking material (TMM) (Teirlinck,
Bezemer et al. 1998) with a vessel-mimicking material made from c-flex tubing (Cole-Parmer,
London, UK). Perspex boxes of dimension 30 x 10 x 10 cm (L x W x D) (Mike Bisset Plastics,
Livingston, UK) were used to build the phantoms. Stainless steel rods of the appropriate
diameter (RS Components, Corby, UK) were pushed through the tubing, which was
subsequently pushed through the sides of the boxes and sealed with silicon. The liquid agar
TMM was poured into the boxes.

When the agar had set, the stainless steel rods were

withdrawn, creating the arterial lumen inside the vessel mimic.

Figure 2.1. Schematic of the phantom flow system used in the study of (Blake, Meagher et al.
2008)
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Each vascular phantom was connected into a flow driven by a gear pump (Micropump model
132, Micheal Smith Engineers Ltd., Surrey, UK) powered by an electric motor (M586TE,
McLeannan Servo Supplies Ltd., Surrey, UK) and an external amplifier (4020-LS, Aerotech
Ltd., Berkshier, UK).

For the brachial and fetal aorta phantoms the working fluid was

acoustically equivalent to human blood.

Figure 2.2. Schematic diagram of the flow circuit used in the study (Blake, Meagher et al. 2008).

There is a need to develop a method for validation of velocities measured in the region of
a stenosis. This paper describes the development of a paired-phantom system for validation of
velocity in the region of a stenosis, based on the use of particle image velocimetry. (Blake,
Easson et al. 2009) developed a dual-phantom system for validation of velocity measurement in
stenosis models.

Pairs of phantoms with identical geometry and flow conditions were

manufactured, one for ultrasound and one for particle image velocimetry (PIV). The PIV model
is made from silicone rubber, and a new PIV fluid was made that matches the refractive index of

37
1.41 of silicone. Dynamic scaling was performed to correct for the increased viscosity of the
PIV fluid compared with that of the ultrasound mimic. The degree of stenosis in the model pairs
agrees to less than 1%. The velocities in the laminar flow region up to the peak velocity location
agreed to within 15%, and the difference could be explained by errors in ultrasound velocity
estimation. At low flow rates and in mild stenosis, good agreement was observed in the distal
flow fields, excepting the maximum velocities. At high flow rates, there was considerable
difference in velocities in the postenosis flow field (maximum centerline differences of 30%),
which would seem to represent real differences in hydrodynamic behavior between the two
models. Sources of error included: variation of viscosity because of temperature (random error,
which could account for differences of up to 7%); ultrasound velocity estimation errors
(systematic errors); and geometry effects in each model, particularly because of imperfect
connectors and corners (systematic errors, potentially affecting the inlet length and flow
stability)

Figure 2.3. Components of the PIV system used in the study of (Blake, Easson et al. 2009).
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Briefly, the flow circuit consisted of the vessel phantom described before connected to a gear
pump at one side and a reservoir at the other side. The inlet was flush with the channel in the
flow phantom and straight for a distance of one meter to ensure fully developed flow at the
isonation site. The gear pump was computer controlled and able to provide steady or pulsatile
flow. The blood mimic consisted of suspension of 5 micron nylon particles in a glycerol/dextran
solution whose acoustic and viscous properties were blood equivalent. The flow rate through the
circuit was measured with a graduated cylinder and a stopwatch.

Figure 2.4. Schematic of the stenosis geometry with 30% diameter reduction (length not to
scale). Obtained from the study of (Shuib, Hoskins et al. 2011).

Laser Doppler velocimetry (LDV) has been used to provide quantitative flow
information, providing spatial velocity profiles and wall shear stresses (Bharadvaj, Mabon et al.
1982; Motomiya and Karino 1984; Ku and Giddens 1987; Rindt and vonSteenhoven 1996). In
the study of (Motomiya and Karino 1984), detailed quantitative information on flow streamlines
within the carotid bifurcation by photographing a suspension of polystyrene particles in
wintergreen oil using a cine camera were obtained. Images were analyzed frame by frame to
provide detailed maps of flow lines, including quantification of flow velocities, and of wall shear
stresses. The studies demonstrated that there is a large flow recirculation region in the carotid

39
sinus where wall shear stresses are very low, whereas along the inner walls of the bifurcation the
flow is parallel to the vessel walls and shear stresses are high. The regions of low wall shear
stress correlated well with the known tendency of atherosclerotic lesions to form in the carotid
sinus, with the inner walls of the bifurcation typically remaining disease-free (Samuel 1956;
Solberg and Eggen 1971).

This study represented a precursor to current particle image

velocimetry (PIV) techniques, which use sophisticated computer algorithms to analyze the
particle images.
Color Doppler ultrasound imaging (DUS) provides an additional means to visualize and
quantify the flow in models of the carotid bifurcation.

In vitro DUS studies of a carotid

bifurcation model, (Polak, Oleary et al. 1990) showed regions of flow reversal in the carotid
sinus. This corresponds to the region of flow reversal and recirculation observed by flow
visualization techniques and LDV. Although most previous in vitro studies have been performed
in models of healthy arteries, the flow through a carotid bifurcation model with a 25% stenosis in
the sinus has also been investigated (Palmen, Vandevosse et al. 1994; Gijsen, Palmen et al.
1996). Hydrogen bubble visualization, LDV measurements, and corresponding computational
flow dynamics CFD analyses showed that this minor stenosis had only a small effect on the flow
fields.
The experimental techniques currently available for quantitative analysis in arterial flow
models each have their unique strengths and weaknesses. Previous quantitative studies in the
carotid bifurcation have mainly used LDV, which provides high spatial and temporal resolution
;10 mm, ;100 kHz!. However, LDV is very tedious when used to map a velocity field, since the
velocity can only be measured at a single point at one time. PIV techniques are far more
efficient, since the velocity field over an entire plane of the model can be measured
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instantaneously. However, PIV has lower spatial and temporal resolutions ~.0.25 mm, and
typically 15 Hz; up to 1000 Hz available at prohibitive cost. Both LDV and PIV can only be
used in transparent models. DUS and magnetic resonance velocimetry (MRV) both have rather
low spatial resolution compared to LDV and PIV ~cf. 3 mm for DUS and 1 mm for MRV.
However, DUS and MRV both have the advantage that they can be used in vivo, enabling direct
comparison between in vitro and in vivo studies. Modeling or measuring wall and fluid shear
stresses is challenging even in healthy blood vessels. Even more daunting is the characterization
of shear stresses in the highly irregular lumen of a diseased blood vessel. Currently, no available
technique can measure the real time distribution of velocities in vivo, and therefore shear stresses
have been, at best, estimated.
2.8 Literature Review Conclusions
A review of literature on numerical and experimental modeling of the cardiovascular
system under diseased and non-diseased cases has been presented. For DES modeling, the drug
release in the arterial walls via DES, computational arterial hemodynamic studies, and arterial
phantoms has been presented.

Presently, the majority of DES studies have incorporated

reversible binding reactions. The most noteworthy recommendations for DES studies are: (1)
incorporating factors related to the pathological conditions; such as plaque, thrombus, and
regions of tissue compression, (2) incorporating design optimization studies with reversible
reacting mechanisms, and (3) including modeling the coating and finite drug reservoir, the
presence of thrombus, or allowing for neighboring or overlapping stents. The latter might require
the inclusion of luminal flow in the model to achieve the correct delivery patterns.
For arterial phantom studies, future studies need to capture the effects of local
hemodynamics on global hemodynamics. In the case of computational arterial hemodynamic
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studies, although the studies based on 2-D models have revealed some key features in fluidstructure interaction, there is a need nonetheless to develop three-dimensional models to define
the physiognomies that only occur in realistic systems. Three-dimensional models can provide
insight on realistic issues that occur in blood flow in the arterial network such as nonaxisymmetric buckling of the tube and secondary flow. There are relatively few theoretical
investigations of flow in three-dimensional collapsible tubes. The next chapter presents the
methodology of the present study.
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3 CHAPTER 3
Methodology
In Chapter 3, the measuring tools, flow loop components, design requirements, and
calibration techniques developed and used in the present study are discussed. It is important to
know what a measuring tool cannot do as well as what it can do before a final selection is made.
Each measuring tool has advantages and disadvantages, and the degree of performance is directly
related to how well a measuring tool‟s capabilities and shortcomings are matched to the working
environment and application. A thorough explanation of the selection of each measuring tool is
provided in addition to decision matrices which were developed and used as a down selecting
tool in the design process. The design requirements for the cardiovascular phantom developed
for the present study is presented. The process developed for designing and calibrating the
phantom flow loop is also presented. The next section presents a discussion on the design
requirements and design processes of the pulse duplicator and cardiovascular phantom.

3.1 Cardiovascular Phantom CAD Model Development
In the present study, an experimental cardiovascular phantom consisting of the major
arteries that deliver blood from the heart to the head and feet is presented. The schematic
presented in Figure 3.1a provides an overview of the major arteries that are modeled in the
cardiovascular phantom.

The schematic in Figure 3.1b is a CAD model schematic of the

cardiovascular phantom which was created in Solidworks. The CAD schematic was used to
create the mold for fabricating the phantom. The CAD model presented in Figure 3.1b was also
used as a geometry mesh for the digital cardiovascular phantom used for CFD simulations which
are presented later in Chapter 4 (specific objective 2).
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Figure 3.1. Full cardiovascular system: (a) schematic representation of arterial system, and (b)
Cardiovascular phantom CAD model.

The CAD model was created from patient-specific CTA scans. A Matlab code was
written to upload the CTA scans of each artery, calculate the centroids, and produce surface
splines at each discrete cross section along the lumen centerline to create the solid geometry.
The process of generating the CAD model is described in more detail below:
1. Import the point cloud CTA image.
2. Calculate the centroids of the arterial fluid core (lumen) contours.
3. Translate the data so the fluid core is centered at the origin of the coordinate axes.
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4. Estimate the centerline of the fluid core.
5. Rotate the data so that the centerline is aligned with coordinate axis.
6. Calculate the hydraulic diameter of the inlet.
7. Create surface splines at each cross section along the centroids.
8. Create a flow extension to ensure fully developed flow.
9. Export the new coordinates for the lumen cross section to Solidworks.
10. Unite the surface splines using the boundary boss base feature.
To align the fluid core with the x-axis, an estimate of the centerline had to be made. This
was accomplished using cubic spline interpolation.

The cubic spline produces a smooth

continuous curve. Matlab contains in-built functions for implementing cubic splines, however
the cubic spline method is described below.






Si  ai  bi ( x xi )  ci ( x xi )2  di ( x xi )3

for x  [ xi , xi  1]

Eqn. 3.1

For a spline with “n” centroids, there are n-1 cubic polynomials that have a total of 4n-4
unknowns. Continuously constraints account for 2n-2 unknowns:
Si ( xi )  ai

Eqn. 3.2a

Si ( xi 1 )  Si ( xi  1)  ai 1

Eqn. 3.2b

smoothness in the first and second derivatives for the interior curves account or another 2n-4
unknowns:
S 'i 1 ( xi 1 )  S 'i 1 ( xi 1 )

Eqn. 3.3a

S ''i 1 ( xi 1 )  S ''i 1 ( xi 1 )

Eqn. 3.3b

The last two constraints are handled in Matlab with the “Not-a-Knot” constraint. This constraint
is applied at the first two or last two cubic curves and matches the third derivatives of the paired
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polynomials:

S '''1 ( x2 )  S ''2( x2 )

Eqn. 3.4a

S ''n2 ( xn2 )  S ''n2 ( xn2 )

Eqn. 3.4b

with the estimate of the centerline calculated, the geometry data can be rotated to align the fluid
core with the x-axis. To rotate the geometry data a rotation matrix had to be constructed.
Equation 3.5 is a generalized rotation matrix:

 u12  (1  u12 )c u1u2 (1  c)  u3 s u1u3 (1  c)  u2 s 


R  u1u2 (1  c)  u3 s
u2 2 (1  u2 2 )c
u2u3 (1  c)  u1s 
u1u3 (1  c)  u2 s u2u3 (1  c)  u1s u32  (1  u32 )c 



Eqn. 3.5

where

c  cos

Eqn. 3.6a

s  sin 

Eqn. 3.6b

and u  (u1 , u2 , u3 ) is the axis of rotation and  is the angle of rotation. In the case of aligning
the fluid core with the x-axis, u is determined by the cross product between the slope of the




centerline estimate at the first contour, n , and the unit vector along the x-axis, x . The angle is
determined by using the four-quadrant inverse tangent, atan2 function. This allows for accurate
calculation of the angle of rotation even when the two vectors are nearly parallel.
The coordinates of the points from the original CTA point cloud images were defined on
a cartersian coordinate system set far from the origin. The contours were translated and rotated
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to have the first contour of the fluid core centered on the origin and the centerlines of the
geometry were estimated to allow the fluid core inlet to be aligned to the x-axis. The hydraulic
diameter of the fluid core was calculated to create the flow extension to ensure fully developed
flow. This also allows the application of an unsteady inlet boundary condition. The hydraulic
diameter is defined in Equation 3.7.
Dh 

4A
P

Eqn. 3.7

where A is the cross-sectional area and P is the wetted perimeter. The flow extensions are 0.06
times the systolic Reynolds number in length. The method of calculating the Reynolds number
is provided in Eqn. 3.8.
Re 

VD


Eqn. 3.8

The entrance length was chosen to allow for a smooth transition to the irregular crosssection of the arterial lumen during the lofting process and to allow the diffusion of the viscosity.
The flow extensions also allow the flow to develop to the patient-specific geometry. The lofting
process was completed in Solidworks. The cross-sectional contours along the centerline of the
model were united using the boundary boss base feature. The solid CAD model was used to
create a mold for the cardiovascular phantom. The CAD model was also used for the digital
cardiovascular phantom for CFD simulations.

For CFD studies the digital cardiovascular

phantom was looped such that the phantom had only one inlet and one outlet. The boundary
condition for the inlet was an unsteady velocity profile specified by a user defined function (udf).
The user defined function was used for both regular flow and dye trace studies. The next section
presents the cardiovascular phantom design fabrication process.
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3.2 Cardiovascular Phantom Design Fabrication Process
The design criteria of the phantom and pulse duplicator that was used in the design
process are listed. The experimental cardiovascular phantom should:
1. Be made from a material that can mimic the compliance of the arteries.
2. Be made from a material that allows flow visualization for dye transport and
physiological Peclet numbers.
3. Instrumented such that physiological parameters (flow rate, pressure, wall shear
stress, and normal stress) can be determined.
The pulse duplicator should:
1. Be capable of producing simplified and patient-specific volumetric waveforms.
2. Be capable of performing user defined physiological parameters (temperature,
pressure limits, volumetric waveform, and frequency)
3. Measuring diagnostic parameters.
The material used to construct the arterial vessels is a clear silicone material that matches
the elasticity of human arteries and is optically transparent for flow visualization. The CAD
model was sent to United Biologics for processing.

United Biologics used a lost casting

technique to produce the cardiovascular phantom for the present study.

A picture of the

cardiovascular phantom prior to connecting to the pulse duplicator, flow measuring devices,
compliance chamber is presented in Figure 3.2. A decision matrix that was used to select the
pulse duplicator for the present study is presented in Table 3.1.
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Figure 3.2. Cardiovascular phantom prior to looping with components.
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Table 3.1
Pulse duplicator decision matrix.
Pulse Duplicator
Criteria

Weight %

1
United Biologics
25

Accuracy

5

2
Harvard
Apparatus

30

35
15

25

15

25
25

25

5

25
10

25
5

15
15

Total

25
15

25

Cost

35
40

25

Ease of Use

20

35
35

Functionality

3
BDC Labs

100

75

15

55

15

80
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The pulse duplicator that was used in the present study is a custom made BDC Labs pulse
duplicator. In the present work, the pulse duplicator acts as the pumping heart; therefore with the
pulse duplicator and the appropriate components, the local hemodynamics of the major arteries
and vascular bed within the arterial system can be simulated. The pulse duplicator used in the
present study is capable of producing physiological data and allowing more user defined
functionality than previous studies have. The pulse duplicator is capable of producing simplified
and patient-specific aortic volumetric waveforms for rest-state and exercise conditions. The
maximum systolic volumetric waveform for the present study is 17 L/min. The pulse duplicator
is also capable of producing user defined volumetric waveforms with the capabilities of adding
on harmonic terms for the input waveform.

The pulse duplicator is programmable for

controlling the temperature of the working fluid, the frequency of the flow (heart rate),
volumetric flow rate, pressure limits and stroke volume. The pulse duplicator has its own data
acquisition software for monitoring real time volumetric flow rate and pressure during
experimental runs. The data acquisition software also contains analysis capabilities that allow
the user to analyze waveforms using techniques such as Fast Fourier Transform of output
waveforms and signal analysis.
In addition to producing user defined volumetric waveforms, the pulse duplicator has its
own in-built compliance chamber for allowing the user to control the compliance of the system.
The pulse duplicator is a highly repeatable and a controllable pulsatile pump. A picture of the
data acquisition used for the pulse duplicator is provided in Figure 3.4. The next section presents
the flow meter and pressure measuring devices that were considered for the present study and the
devices that were chosen.
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(a)

Flow controls

Flow charts
(b)

Figure 3.3. Photograph of: (a) pulse duplicator, and (b) screenshot of pulse duplicator data
acquisition software.
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3.3 Flow Meter and Pressure Measuring Device Types Considered
The first flow measuring device that was selected for the present study was a flow meter.
There are a variety of methods available to measure volumetric flow rate. Table 3.2 provides a
list of commonly used flow meter device types that are used in flow applications. Table 3.3
presents the decision matrix that was developed and used as the down selecting tool for the flow
meter device type selection process. From the decision matrix listed in Table 3.3, a restriction
flow metering device was deemed to be the most suitable choice for the present study. The
following presents a discussion on the reason why the alternative choices were not used:

Table 3.2
Flow meter device types and specifications.
Mechanism
Nominal Accuracy*
Restriction flow
meters
Linear flow meters

Dependent on the
differential pressure
device
0.05

Traversing Methods

0.2

Flow-sensitive or
summing element
Nozzle type opening

Operating Range

Float type, turbine,
vortex, and
electromagnetic
Thermal anemometers

0.25-160 L/min

4:1 Range

0.38-1000 L/min

Restriction flow meters for internal flow are based on acceleration of a fluid stream
through a diverging area in which the differential pressure is measured using a pressure
measuring instrument. The flow rate can then be inferred using a theoretical analysis or an
experimental correlation device. The most popular restriction flow metering devices are orifice
and Venturi meters. An orifice meter consists of an orifice plate with a machined hole in the
center. The orifice plate is positioned between two straight pipes in length, usually flanged.
When the fluid enters the orifice, it must accelerate due to the flow area being reduced.
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Table 3.3
Flow measuring device decision matrix.
Flow Measuring Devices
Criteria

Weight %

1

2

3

SM600

F1250

Pasco

15
Accuracy

15

15

35
35
15

Functionality

35
15

25

25
25
19

Ease of Use

25
15

25

10

25
10

25
11

15
15

Total

25
25

25

Cost

35

100
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15

55

15

76

The Bernoulli‟s equation describes the corresponding pressure drop that takes place and
is also used to correlate the theoretical mass flow rate. An orifice meter was not used because a
manufactured orifice meter requires at least 12 feet (3.658 m) of piping from the pipe connection
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adapters to achieve the correct pressure drop to correlate a flow rate reading. As a result, the
orifice meter is not space accommodating. The Venturi meter consists of a conical entrance and
exit section connected by a reduced cross section area in length. The reduced area section is
recognized as the throat of the Venturi.
Similar to the orifice meter, the Venturi meter is also based on the reduction of flow
pressure accompanied by an increase in velocity. The pressure drop experienced is used to
measure the rate of flow through the Venturi meter. On the discharge side of the meter, the fluid
velocity is decreased and the original pressure is recovered. Because of the shape of the Venturi
element, the pressure losses in a Venturi meter are less than in an orifice meter. The derivation
and clarification of the correlation between theoretical mass flow rate and pressure drop can be
found in (Fox R. 2004). A Venturi meter was not used because a Venturi meter requires molding
and casting of the Venturi element.

Hot-wire anemometers is another method used for

measuring flow rate and is a traversing method. Hot-wire anemometers were not considered
because the phantom material is sensitive to heat transfer and will deform and break under
extensive heat.
From the decision matrix listed in Table 3.3, a Pasco Spark data acquisition system, with
single pressure and differential pressure measuring and data capturing capabilities were chosen.
The Pasco system was used to measure pressure at a point and to measure the volumetric flow
rate of the pulsatile flow via differential pressure. An in-house wedge flow meter that was
constructed from a PVC pipe was used in conjunction with the pasco pressure measuring device.
The wedge flow meter element operates based on differential pressure. The spark system is
factory calibrated to infer a volumetric flow rate reading based on differential pressure for flow
metering elements. The second flow metering device is pulse duplicator itself which contains an
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inbuilt flow meter. The cardiovascular phantom was connected to a fluid flow loop which
consisted of a compliance chamber/fluid reservoir, pulse duplicator, two pressure meters (head
and feet), and a flow meter. A Tilt table was also installed to test the phantom during transition
from bed-rest to upright position. Figure 3.4 shows the phantom connected to the loop.
Phantom

Pasco
System

Tilt
Table

Flow
meter

Compliance
Chamber

Figure 3.4. Photograph of cardiovascular phantom with looped components and tilt table.
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3.4 Design of In-house Particle Imaging Velocimetry System
An in-house PIV system was designed and built for the present study. As mentioned
earlier in Chapter 3, PIV consists of capturing images of small spherical hollow glass particulates
moving with the flow field. The images are processed using software to determine information
on the flow such as flow patterns, flow trajectory, and flow parametric data. The in-house PIV
system used in the present study consisted of two high speed Basler acA2040-180 km CMOS
cameras in conjunction with a PIXC1-E8 frame grabber (Epix, Inc.) which captured images of
the particulates moving with the pulsatile flow field. Navitar NMV-35M1 lenses are used, which
have an effective focal length (EFL) of 35 mm. The lenses have a minimum f-number of 1.4.
The frame grabber is a Camera Link frame grabber that is able to capture the camera frame rate
sequence using 1.4 Gbyte/sec burst transfer. The frame grabber is housed in an IBM Desktop
computer with a PCI Express x8 79 bus slot and 512 MB of memory. The sensor and frame
grabber was controlled using XCAP-Std software (Epix, Inc.) which allowed for sequence
capture and manipulation of images.
The pulsatile flow field is illuminated by creating a laser light sheet using a MGH-H-532,
solid-state green laser (Opto Engine) with a power output of 1.4 W. A 60° lens is attached to the
laser as a line generator to create the light sheet. The laser was operated at a wavelength of 532
nm which was capable of producing a 1.5 mm thick. Figure 3.5 provides a photograph of the
PIV system setup with the laser and cameras. The in-house PIV system uses open-source PIV
processing software called PIVlab_1.32. The code uses time-resolved PIV to pair images and
calculates the velocity distribution. The code is also able to derive, display, and export many
other parameters of the flow field.
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(a)

(b)
Cameras

Phantom

Laser

(c)
Figure 3.5. Photograph of PIV system (a) and (b) laser and (c) system setup.

Images can be analyzed using either Fast Fourier Transform (FFT) or direct cross correlation
(DCC). For the present study the direct cross correlation technique is used for all analyses. Prior
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to conducting any PIV analyses, the PIV system had to be calibrated to insure accurate
measurements.

The system was calibrated via gravity driven flow and Womersley flow

(pulsatile flow). Analytical results were compared to experiments and were found to be within
3% agreement. The next section presents the gravity driven flow PIV calibration methodology
and results.

3.4.1 Gravity Driven Flow PIV Calibration
For gravity-driven calibration, a simple, gravity-driven pipe flow problem was setup to
test the accuracy of the system.

Figure 3.6 shows a CAD schematic of the pipe flow

experimental setup. A cylindrical polycarbonate tube (test tube) was used for testing. The outer
diameter was 0.19m, inner diameter 0.016m and the length of the pipe was 0.61 m. The test tube
was constructed so that the fluid was discharged through a circular orifice, 3.57 mm (9/64”) in
diameter. A constant pressure head was maintained to ensure a constant volumetric flow rate. A
beaker was used to capture the fluid and a mass balance and stop watch was used to measure the
mass of the fluid as a function of time to infer a volumetric flow rate measurement. For
comparing the PIV results to the analytical solution of gravity-driven pipe flow, the solution had
to be derived from the Navier Stokes equation. A simple explanation of the solution is provided
here. Assuming one-dimensional (1D) flow, with gravity as the driving force, the parabolic
velocity profile (analytical solution) can be obtained from:
u z (r ) 

 gR 2  r 2 
1 

4  R 2 

Eqn. 3.9
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Test clamp

Laser

Test stand
Test tube

Laser light
sheet

Camera

Beaker

Figure 3.6. CAD Schematic of gravity-driven calibration setup.
The volumetric flow rate is obtained from the following:




R

Q   v  d A   uz (r )  2 rdr 
0

 g R 4
8

Eqn. 3.10

the average velocity Vag is given as:
Vavg 

Q
Q

A  R2

Eqn. 3.11
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the point of maximum velocity is found to be at r = 0, or at the centerline of the pipe. Therefore,
the maximum velocity is given as:


Vmax  2V

Eqn. 3.12

The volumetric flow rate in the pipe is equal to the flow rate exiting the orifice due to continuity.
So the velocity in the pipe can be determined. Prior to analyzing results, an interrogation
window and grid step independent study was conducted. Table 3.4 shows the increments of
pixel and step sizes used. The interrogation/grid step sizes were changed in increments of 10
pixels. The results were shown to be independent of interrogation area at 64 pixels and 32 pixels
for grid steps sizes.

Table 3.4
PIV Interrogation Grid Independent Study.
Interrogation area [px]

Grid (step) size [px]

Algorithm

Centerline Velocity (m/s)

44

12

DCC

0.160

54

22

DCC

0.175

64

32

DCC

0.180

74

42

DCC

0.180

Figures 3.7a and 3.7b show the images that were processed in PIVlab_1.32. Figure 3.7a is the
first of a series of images that were deployed to be analyzed and b is the resultant vector plot.
Figure 3.7a shows the PIV results and analytical solution of the gravity driven pipe flow. Figure
3.7c displays the contour and vector plot of the measured velocity, which shows the parabolic
nature of the velocity flow field. The parabolic shaped profile is observed from the Poiseuille
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flow problem and is evident in the results. Figure 3.8 shows the comparison of the analytical and
the experimental solution. The results are within 3 percent agreement. From Figure 3.8, it is
shown that the largest contribution to error is at the wall were the reflection of the laser light
distorts the image. However the no-slip condition is known to take place at the wall of the tube
and rectifies this error and the error can be minimized at the wall by using vector smoothing.

(a)

(b)
0.2

Velocity (m/s)

0.15

0.1

0.05

0

(c)

0

0.002 0.004 0.006 0.008 0.01 0.012 0.014 0.016
Diameter (m)

(d)

Figure 3.7. PIV Processing methodology
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Figure 3.8. Calibration plot of gravity-driven flow with analytical and experimental solution.

3.4.2 Womersley Flow PIV Calibration
For comparing the PIV results to the analytical solution of Womersley flow, the solution
had to be derived from the Navier Stokes equation in cylindrical coordinates.

A simple

explanation of the solution is provided here. The flow is assumed to be 1-D flow, with an
oscillating pressure gradient. The oscillating pressure gradient is given as:
P


 Re   an e j nt 
z
 n 0


Eqn. 3.13

where n is the number of harmonics, an is the amplitude, j is an imaginary number, n is the
number of harmonics, and ω is the frequency. With the oscillating pressure gradient as the
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driving force and through much manipulation, the velocity profile (analytical solution) can be
written as a harmonic series equation as a function of radius and time:


u ( r , t )  uo ( r )   u n ( r , t )

Eqn. 3.14

n 1

where
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Eqn. 3.15

the solution applies to the results of each harmonic. To find the velocity as a function of radius r
and time t for the entire driving pressure, the steady flow (Pousellie flow) result uo is added to
the results for all harmonics. For the present study shear stress is a major parameter of interest.
The shear stress can be found from:

 (r , t )  

uo (r )  un (r , t )

n 1
r
r

Eqn. 3.16

To expand the form of the shear stress equation the derivative terms are needed:
uo ao

r
r 2 

Eqn. 3.17
and
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Eqn. 3.18

Thus, the oscillatory shear stress can be written as:

n 
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Eqn. 3.19
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For pulsatile experiment calibration, the frequency of the flow was 70 beats per minutes
(1.2 hertz), maximum systolic pressure of 90 mmHg, and a maximum flow velocity of 0.45 m/s.
Figure 3.9 shows the measured velocity and pressure profile. The velocity and pressure was not
measured at the same point. The captured data is for 4 cycles. Figure 3.10 shows the experiment
and analytical velocity profiles at different time steps.

(a)

(b)
Figure 3.9. Pulsatile flow experiment waveforms: (a) volumetric flow rate, and (b) Pressure.
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(a)

(b)
Figure 3.10. Womersley velocity profiles: (a) analytical and (b) experimental.
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The experimental and Womersley velocity profile centerline velocity (maximum velocity) were
shown to be within 3 percent difference in error. Similar to the gravity driven results, the
maximum error was found to be at the wall. The results shown are for one cross-section along
the longitudinal direction (z-direction) of the pipe. A more detailed analysis is needed to
determine if the Womersley solution is valid along the longitudinal direction of the pipe. Figure
3.11 shows the PIV contour and vector plots of the velocity profile of the pulsatile flow.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Velocity
(m/s)

Figure 3.11. PIV velocity contour profiles at: (a) 3.0s, (b) 3.1s, (c) 3.2s, (d) 3.3s, (e) 3.4s, (f)
3.5s, (g) 3.6s, and (h) 3.8s.
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The results for each time step shows that the flow is not symmetric along the centerline. For this
particular case it is important to introduce the Womersley number. The Womersley number is
defined as the ratio of the unsteadiness to viscous. The Womersley number is provided below:

R



Eqn. 3.20

v

In the case of Womersley flow, if the Womersley number is large (greater than 10) and R is
larger, the flow is dominated by unsteadiness.

If the radius of the tube is small, then

unsteadiness is not important and the flow is viscous. For the present study, the Womersley
number is calculated as:

  (0.008m)

1.2s 1
m2
0.45 10
s

 28.22

Eqn. 3.21

6

This calculation indicates that unsteadiness is dominant. When unsteadiness is dominant in
pulsatile flow, the centerline velocity oscillates out of phase with the pressure gradient. Also,
when unsteadiness is present in the system, this means that the velocity profile is not parabolic at
each time step in the cycle. In addition, the velocity profile will not be constant at each crosssection along the axial direction of the pipe. In summary, non-symmetric flow will be present in
the case of unsteady flow. Figure 3.12 provides contour plots and centerline data for the PIV
results. Figure 3.12 provides a clear representation of non-symmetric velocity profile at each
discrete time interval. Figures 3.13a 3.13b and 3.13c also show how the velocity at each discrete
cross-section along the axial direction of the pipe is not constant. This is due to the unsteadiness
of the system in which the Womersley solution cannot be applied. The Womersly solution
assumes that the velocity is constant at each cross-section of the pipe along the axial direction.
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(a)

(b)

(c)

Velocity
(m/s)

(e)
Figure 3.12. Experimental centerline velocity profile.
From the results shown in Figure 3.12e, at times 3.0 and 3.2 the results change in
magnitudes slightly and maintain the same trend in profile. However at time 3.5, the profile
changes due to the increase in velocity magnitude. From these results it is evident that the
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Wormersley solution is only valid for small Womersley numbers or viscous flows. This because
of the unsteadiness introduced into the flow by the harmonics of the waveform.

(a

(b)

(c)

(d)

Figure 3.13. Experimental and computational velocity profile comparisons at(a) 4.3s, (b) 3.7s (c)
3.9s and(d) 4.0s

Figure 3.13 shows a comparison of the computational and experimental velocity profiles at each
time step. The time steps chosen were time steps that were below transition time as shown in
Figure 3.10. The transition time is the time where the experimental and computational profiles
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no longer agree. As shown in Figure 3.13, the maximum error tends to be near the wall. This
error is due to the harmonics present in the system and the distortion of the light sheet entering
the conduit from the laser.
3.5 Dye Mass Concentration Methodology
For the present study, a dye mass concentration study was conducted on the phantom.
The dye mass concentration methodology consists of measuring the dye front of the fluid. A
time dependent point measurement can be taken at any point on the phantom. A detailed
overview of this is provided in Chapter 4. However the methodology is discussed here. The dye
mass concentration method is conducted via optical measurements using a standard LED light
and CMOS camera system. The same camera system from the PIV system is used. The
equation used to measure mass concentration is shown below:
C

msolute
msolution

Eqn. 3.21

Prior to collecting any mass concentration measurements of the dye, the system setup had to be
calibrated. The calibration consisted of creating known concentrations of the fluid (water) to dye
and measuring the intensity. A Matlab script file was written to measure the intensity of images.
The intensity could then infer a concentration measurement. It is assumed that both the ratio of
initial intensity to indexed intensity is proportional to the ratio of initial concentration to indexed
concentration as shown below:
I 0 C0

I
C

Eqn. 3.22

The intensity script written in Matlab collects the images and converts the image to a
scaled grey image of 256 levels of gray. The 256 level of gray (all white) is considered to be the
0 concentration of fluid (no dye). The 0 level of gray which is all black is considered to be 1
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concentration (black). Figure 3.14 shows the test tube with a concentration of dye to water and
the LED light used. The script creates a measurement line across the tube and measures the
average intensity across the diameter of the test tube. The test tube is made of the same material
as the phantom so that an accurate mass concentration measurement could be made.

LED light

Test tube

LED light

(a)

Test tube
(b)

Figure 3.14. Dye Mass Concentration apparatus setup: (a) LED light of with a known mass
concentration in fluid and (b) Light on with known mass concentration.

Eight mass concentrations were made ranging from 0 to 1. Each mass concentration was
converted to intensity and a calibration plot was generated.

The calibration plot of the

Concentration vs. Intensity is shown in Figure 3.15. The calibration equation is shown and the R
value for the line of best fit is 0.9975. The next section presents the stent geometry generation
methodology for CFD.
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Figure 3.15. Calibration plot of Dye Mass Concentration setup.

3.6 Stent Geometry Modeling and CFD Modeling Methodology
The three in-house stent design patterns evaluated in the present work are similar to stents
manufactured by Abbott Laboratories (Abbott Park, Illinois, U.S.A.) and Biosensors (Europe,
SA (BESA), Switzerland). The geometric details of each stent are provided in Table 3.5. To
make a design comparison, representative geometries for each stent are constructed with the
same strut: diameter (5 mm), length (24 mm), and thickness (0.24 mm). The

strut spacing

for each stent design evaluated is representative and differs to some extent from commercially
available stent designs. Figure 3.16 shows the flattened out geometries for the three in house
stent designs. The flattened out geometries shown in Figure 3.16 were created in Solidworks.
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The flattened geometry was sketched on a plane, extruded to the required thickness, and then
converted to a circular meshed tube (stent) using a wrap feature. For CFD simulations in the
present work, the flow in the carotid bifurcation artery is Newtonian, laminar, and
incompressible.

Table 3.5
Geometric details of stent models.
Model label

A

B

C

Number of Columns

10

10

10

Number of Struts

42

10
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Outer diameter

5 mm

5 mm

5 mm

Strut thickness

0.24 mm

0.24 mm

0.24 mm

20.25 mm

20.25 mm

20.25 mm

Aspect Ratio (e/d)

0.048

0.048

0.048

Aspect Ratio (e/L)

0.012

0.012

0.012

Aspect Ratio (d/L)

0.250

0.250

0.250

Length

The physiological assumptions used in the present work has also been used in the work of
(Siauw, Ng et al. 2000; Zhao, Ariff et al. 2002; Farmakis, Soulis et al. 2004; Giannoglou, Soulis
et al. 2005; Cheung, Wong et al. 2010). Blood is modeled by the incompressible Navier-Stokes
equations with blood density specified as 1060 kg/m3 and the corresponding kinematic viscosity
0.0032 m2/s.

The commercial software ANSYS was used for geometric meshing and

FLUENTTM was used to solve the Navier-Stokes equations in the finite volume formulation.
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Figure 3.16. Stent designs used for the present study.
Numerical simulations were performed for simplified arterial stented cores and patientspecific arterial stented cores.

Figure 3.17 shows the simplified arterial stented cores and

patient-specific arterial cores that were evaluated in the present work. The simplified arterial
stented cores consisted of a half-plane stented segment since the stent is axisymmetric as shown
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in Figure 17b. The patient-specific stented core consisted of an arterial geometry obtained from
a computed angiographic (CT) scan of a 50 year old male as shown in Figure 16c. The image
contained a point cloud, which defines the surface geometry of the carotid bifurcation by discrete
domains. The image was processed in CAD software called Solidworks using a curve creation
feature. The curve creation feature united the point cloud with 3-D surface splines. This
technique was repeated at each domain until the entire arterial geometry was defined. Each 3-D
spline domain was then united using a lofting and boundary boss feature until the final solid
product was obtained. This process is outlined in (Hewlin and Kizito 2011). The arterial wall at
the stented region for both the simplified arterial stented core and the patient-specific arterial
stented core is straight with constant diameter.

Figure 3.17. Arterial stented fluid cores evaluated for the present study.
The three dimensional stented regions were created in Solidworks with a solid cylinder
dimensioned 1.5 times the length and the diameter of the core is the same as the stent. The core
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geometry represents full strut exposure to the blood flow. The stent geometry and the solid
cylinder were united using the mating feature then removed using a Boolean operator in which
the geometry of the stent is removed from the cylinder and the stent geometry impression
remains in the cylinder. The models are discretized and used as computational domains. Grid
meshing levels were performed at three levels: coarse (132,226), coarse (155,998) and medium
(306,085). A sinusoidal velocity waveform boundary condition was specified at the inlet and the
outlet(s) was modeled as pressure outlets at 12 kPa (90 mmHg).

The No-slip boundary

conditions were imposed at the walls. The flow velocity amplitude in the inlet of each stented
core was set to 0.2 m/s and a heart rate of 168 beats/min (2.8 Hz) to simulate normal cardiac
behavior.

The comparison of the velocity magnitude at the ICA for arterial stented core

geometric models resulted in a 0.32% difference in velocity in a grid independence study. With
such a small difference, simulation results were independent of the computational mesh when the
disparity between mesh spacing varying densities was less than 1%. For numerical solutions, the
velocity coupling solving technique was implemented. Table 3.6 presents the grid independent
study.
Table 3.6
Arterial geometry mesh independent study data.
Number of Cells
104,406

Wall Shear
15 Pa

Velocity
1.2 m/s

Pressure
99 mmHg

143,948

8.3 Pa

0.51 m/s

90 mmHg

233,045

8 Pa

0.5 m/s

90 mmHg

The WSS, normal stresses, and vorticity values are predicted on fluid domain surfaces that
represent the interface boundary between the fluid, struts, and the neighboring tissue. Figure
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3.18 shows the stented core unit cell schematic and geometric data of each stent design. The
next section presents the DES drug concentration study methodology.

Figure 3.18. Stent Unit cell specifications.
3.7 DES Drug Concentration Study Methodology
Solidworks was used to model the stent deployment to the vessel wall. A schematic of
the artery wall and stent impression is shown in Figure 3.19a. In the present study, a transmural
pressure drop induces filtration of plasma through the vessel wall. The arterial wall was modeled
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as a porous media. The Darcy Law model was used to solve the plasma flow field. Fluent
implements the Darcy Law equation as a source term in the Navier-Stokes equations:

v
 v

 v v   p   2 
K
 t




Eqn. 3.23

where c is the velocity vector, P is the pressure, K is the permeability of the vessel wall, and are
the density and viscosity of plasma. The density of plasma is 1.02 g/cm3 and the viscosity is
0.012 g/cm s. The permeability of the plasma wall was set at 2.0E-18m2.
The arterial wall concentration profile was not solved in conjunction with fluid flow
analyses.

Instead, the models were solved separately. This introduces an assumption because

the flow decreases axial non-uniformity of the drug in the artery wall. The degree of nonuniformity is observed to increase with increasing aspect ratio of stent struts. The impact of the
assumption is minimized by the use of square struts with an abluminal coating which is the case
used in the present study.
3.7.1 Boundary Condition for Drug Transport
The boundary conditions for each zone are provided in Figure 3.19. The „„plasma
velocity inlets‟‟ zone represents the exposed inner surfaces of the artery.

The „„stent

impression‟‟ represents the location where the stent is in contact with the vessel wall. The rest of
the surfaces shown in Figure 3.19 are treated as symmetry planes. For the velocity inlets, a
component (x,y,z) velocity inlet is specified. The normal velocity component (vn) was set equal
to 1.0E-8 m/s. The tangential velocity components were set equal to zero on the „„velocity
inlets‟‟ zone. The no-slip condition was applied on stent surface and lumen wall.
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Stent impression

Artery wall

(a)

Plasma velocity inlet boundary
Condition

Drug deposition boundary

Symmetry boundary condition
(b)
Figure 3.19. Arterial and DES CFD geometry model: (a) solid model and (b) computational
mesh.
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3.7.2 Formulation of the Drug Transport Model
For the Drug transport problem, the vessel tissue was modeled as a composite material,
one unbound and bound. The bound material is a collection of drug binding sites, and the
unbound compartment as the neighboring constituents.

Each material is a homogeneous

material. The elution process is modeled such that the drug diffuses out of the stent coating into
the plasma and then partitions into and out of the drug binding site compartment. A two-species
model was used to account for the two materials and the partitioning of the drug between the two
materials. The free transport of the drug into the unbound material which is referred to as C u.
The restrained drug is referred to as the bound drug, denoted Cb. The inter-conversion between
the unbound plasma phase and the bound phase of tissue binding sites is controlled via an
equilibrium reaction described by:
Cu

kF
kR

Cb

Eqn. 3.24

Where kf is the forward reaction rate and kr is the reverse reaction rate, Keq is the equilibrium
coefficient which is equal to the ratio of the forward and reverse reaction. The affinity drug for
the plasma phase decreases as keq increases. The reaction rate R between the bound an unbound
form is:
R  k f Cu  k r C b

Eqn. 3.25

The unbound drug is subject to transport by plasma flow, diffusion, and reaction. The transport
equation for the unbound drug is given by:
Cu
 v Cu  Du  2Cu  R
t

Eqn. 3.26
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where Du is the diffusion tensor for the unbound drug. The unbound drug was assumed to by
completely immobilized in the tissue. This was accompanied by setting v=0, which leads to the
following transport equation for Cb:
Cb
 Db 2Cb  R
t

Eqn. 3.27

where Db is the diffusion tensor for bound drug. The contribution of the diffusion term was
minimized by setting Db=1.e-7Du.

3.7.3 Initial and Boundary Condition for the Drug Transport Model:
The arterial wall was assumed to have no drug present at the time of stent implantation,
therefore the concentration at the wall was set to zero. The boundary conditions for the model
were:
Cu , stent  1

Eqn. 3.28

Cu ,lumen  0

Eqn. 3.29

Cu , sidewalls


0

Cu ,outerwall


0

Eqn. 3.30

Eqn. 3.31

The zero concentration of drug at the lumen assumes a continuous supply of drug in the stent
coating. This is probably the most unrealistic of the applied boundary conditions as it is typical
for the drug to be depleted after 1–3 months. The zero concentration of drug at the lumen also
assumes that the drug concentration in the blood is negligible.

Eqn. 3.30 is a symmetry

condition and Eqn. 3.31 assumes that the convective flux is the dominant transport mechanism at
the far wall. Zero-flux boundary conditions were applied for Cb at all domain boundaries since
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the convective and diffusive components were assumed to be negligible for this drug form. The
next Chapter presents the results for the present study.
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4 CHAPTER 4
Results
4.1 Cardiovascular Phantom Posture Transition Studies
In this section, the present study addresses the cardio- and cerebrovascular responses to
the everyday orthostatic challenge of moving from bed rest to upright standing position. The
vascular pressure change (cerebral and femoral) profiles that occur doing a transition from bed
rest to an upright position on the cardiovascular phantom is discussed. The age range of the
simulated subject (cardiovascular phantom) is 28-40 years of age. The most prominent condition
that is accelerated and progressed by an accelerated change in posture is orthostatic hypotension
and intolerance. The results discussed are addressed to provide insight on the magnitude of
vascular pressure changes and the types of parametric profiles that exist during a transition from
bed rest to upright position.
Orthostatic intolerance is a broad term used for several conditions characterized by
symptoms of light headedness, dizziness and faintness on assuming upright posture.

The

underlying mechanism of orthostatic intolerance is the inability of the autonomic nervous system
to maintain adequate hemodynamic behavior of the body during upright posture resulting in
cerebral hypoperfusion which leads to its symptoms. Upright posture is the most physiological
orthostatic stressor and it imposes stress leading to gravitational pooling of blood in the
splanchnic venous reservoir and leg veins. On standing 300 to 500 ml of blood is forced
downward to the abdominal area and lower extremities. A healthy subject is able to reach
orthostatic stabilization in 60 seconds or less by an increase in sympathetic outflow resulting in
vasoconstriction of capacitance and arteriolar vessels. However, in patients with orthostatic
intolerance this compensatory mechanism is disturbed and reflex mediated changes in autonomic
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nervous system leads to decreased vascular tone, heart rate and cardiac output with resultant
acute cerebral hypo perfusion. Normally a reproducible cardiovascular reactivity (CVR) pattern
mediated via autonomic nervous system results in slight increase 10–15 bpm in heart rate and
blood pressure 10–15 mmHg (1.33-2 kPa) to balance the situation. When autonomic nervous
system is dysfunctional normal CVR pattern is altered so that blood pressure is not maintained at
adequate levels during upright posture resulting in cerebral hypo perfusion and symptoms of
orthostatic intolerance.
In the absence of volume depletion, younger patients with orthostatic hypotension usually
have chronic autonomic failure. A related problem, postprandial hypotension, is common in
older patients and those with autonomic dysfunction. In postprandial hypotension, there is a
decrease in systolic blood pressure of at least 20 mmHg (2.7 kPa) within 75 minutes of a meal.
A normal hemodynamic response to changes in posture requires normal function of the
cardiovascular and autonomic nervous systems.

Standing results in blood pooling of

approximately 500 to 1,000 mL in the lower extremities and splanchnic circulation.

This

initiates an increase in sympathetic outflow, which increases peripheral vascular resistance,
venous return, and cardiac output, thereby limiting the decrease in blood pressure.

These

compensatory mechanisms result in a decrease in systolic blood pressure 5 to 10 mmHg (0.671.33 kPa), an increase in diastolic blood pressure 5 to 10 mmHg (0.67-1.33 kPa), and an increase
in pulse rate (10 to 25 bpm). However, orthostatic hypotension may result if there is inadequate
intravascular volume, autonomic nervous system dysfunction, decreased venous return, or
inability to increase cardiac output in response to postural changes. Decreased cerebral perfusion
produces the neurologic symptoms of orthostatic hypotension.
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Figure 4.1 presents a plot of the scaled hemodynamic flow parametric flow profiles. The
flow profiles are scaled and plotted on the same graph to show that a time lag exists between the
profiles. The volumetric flow rate waveform is scaled with the maximum flow rate, which is the
flow rate at systole and the pressure waveform is scaled with the maximum pressure at systole.
As shown in Figure 4.1, there is a time lag from the systolic peak of the pressure waveform to
the systolic peak of the flow rate wave form (peak to peak) at 0s, 1s, 2s, and 3s. However, the
time lag at 1s is different between the time lag at 1s, 2s and 3s. This may be due to some
abnormality during startup or during data capturing. The time lag between the profiles is at
systolic peaks is 0.3s, and 0.5s at diastolic peaks. This is due the pulsatile pressure being the
driver of the flow and the flow rate being the response. Also in the present study, a static trial
was conducted to measure the pressure change from cerebral (head) to femoral (feet) during bed
rest (lying down) and upright (standing up).

Figure 4.1. Static parametric flow profiles: (a) unscaled volumetric flow rate, and (b) scaled
volumetric flow rate and pressure.
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The negative flow rate observed in Figure 4.1 is due to a regurgitation of flow (reverse flow).

Head

Feet
(a)

Head

Feet
(b)

Figure 4.2. Static trial run pressure results for: (a) lying down and (b) standing up (upright).

Two heart rates were evaluated (60 and 65 bpm) to simulate rest state (normal heart rate)
and semi-exercise (accelerated heart rate). Figure 4.2 provides a plot of pressure changes from
head to feet in both lying down position and upright position. From Figure 4.2, during the lying
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down position and during rest state cycle, the head systolic pressure is 14 kPa (105 mmHg) and
the head diastolic pressure is 2 kPa (15 mmHg). During the semi-exercise (accelerated heart
rate) cycle and lying down, head systolic pressure is 17.2 kPa (129 mmHg) and head diastolic
pressure is 5.8 kPa (43.5 mmHg). During the lying down position and during rest state cycle,
feet systolic pressure is 10.2 kPa (76.5 mmHg) and the feet diastolic pressure is 5.4 kPa (40.5
mmHg). During the semi-exercise (accelerated heart rate) cycle and lying down, head systolic
pressure is 17.2 kPa (129 mmHg) and head diastolic pressure is 5.8 kPa (43.5 mmHg). For
upright position and during rest state, the head systolic pressure is 10.4 kPa (78 mmHg) and the
diastolic head pressure is 0 kPa (0 mmHg). During the semi-exercise cycle and in the upright
position, the systolic head pressure is 14.8 kPa (111 mmHg) and the diastolic head pressure is
2.5 kPa (18.8 mmHg). The feet systolic pressure during upright position and during rest state
was found to be 1kPa (7.5 mm Hg) and diastolic pressure was -5 kPa (-37.5 mmHg). The feet
systolic pressure during upright semi-exercise 3 kPa (22.5 mmHg) and diastolic pressure is -4
kPa (-30 mmHg).
A more generalized statement is that the pressure difference from systolic to diastolic is
approximately 12 kPa (90 mmHg) during rest state cycle and exercise, whereas the feet systolic
to diastolic pressure difference during rest state and exercise is approximately 5 kPa (37.5
mmHg). The systolic pressure difference from head to feet during rest state and lying down is 4
kPa (30 mmHg) and the systolic pressure difference during rest state and upright is 9 kPa (67.5
mmHg). The pressure cycles show a shift in time phase between heart rates. The phase shift in
head pressure 0.25 seconds and the phase shift for feet pressure are 0.2 seconds. The pressure
difference between head and feet is important because it gives insight on the level of blood return
to the heart, pressure spikes during posture transition, and magnitude of oxygen transfer.
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Pressure difference is also important when considering accelerated movement from bed rest to
upright position. This pressure difference is referred to as blood pooling. Because of this
pooling, the amount of blood carried back to the heart by the veins is decreased. Subsequently,
less blood is pumped out from the heart, resulting in a sudden drop in blood pressure. By
definition, the drop in blood pressure must be greater than 2.6 kPa (20 mmHg) during
contraction of the heart muscles (systole) and more than 10 mm of mercury during expansion of
the heart muscles (diastole). Normally, specialized cells in the body (baroreceptors) quickly
respond to changes in blood pressure. These baroreceptors then activate the autonomic nervous
system to increase, via reflex action, and increase levels of catecholamines (e.g. epinephrine,
norepinephrine) in the body. Increased catecholamine levels rapidly restore the blood pressure.
A defect in this spontaneous response (reflex) prevents the heart rate and blood pressure from
rising adequately and orthostatic hypotension results.
Figure 4.3 shows a plot of the pressure cycle profiles during transition from bed rest to
upright position. The two pressure cycle profiles simulate two scenarios, an atherosclerotic
diseased stenosis at the ascending aorta (stenosed at 42%) and a hypertension stage 1 patient.
Table 4.1 provides an outline of the stages of hypertension and the analogous hemodynamic
conditions.
Table 4.1
Orthostatic hypertension blood pressure assessment.
Systolic Blood Pressure

Diastolic Blood Pressure

Assessment

Below 120

Below 80

120-139

80-89

Prehypertension

Over 140-159

90-99

Hypertension Stage 1

160 or higher

100 or higher

Hypertension Stage 2

Normal
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From Figure 4.3, the hypertension stage 1 pressure cycle has a maximum systolic pressure of
approximately 136 mmHg in the time range of 3.7 seconds. After 3.7 seconds the phantom is
transition to bed rest to upright position and the systolic head pressure changes to 126 mmHg
(16.8 kPa) at and 124 mmHg at (16.5 kPa) and stabilizes to 120 mmHg (12 kPa). For the
stenosis case, the maximum head pressure is at 159 mmHg (21.2 kPa) in the range of 3.7
seconds. After 2.4 seconds, the pressure spikes to 163 mmHg (21.7 kPa) at 3.44 seconds and
151 mmHg (20.1 kPa) 4.4s and then 149 mmHg (19.9 kPa) at 5.4s and then stabilizes to 145
mmHg (19.33 kPa). From the static condition mentioned previously and referring to Figure 4.1,
the maximum pressure is 70 mmHg (9.33 kPa) for normal conditions in the upright position. A
comparison can be made between normal, stage 1 hypertension and a 42% stenosis case.
The transition pressure difference for normal and stage 1 hypertension is 66 mmHg (8.8
kPa) and the stabilized pressure difference is also 50 mmHg. The most notable difference (6.7
kPa) is the pressure difference during the maximum pressure and transition pressure.

The

transition pressure has to be greater than 2.6 mmHg (0.35 kPa) to avoid blackout. The transition
pressure for stage 1 hypertension is 2 mmHg (0.27 kPa) and the transition pressure for the
stenosed case is 1 mmHg after the spike in pressure during the transition. For both cases the
phantom produces hemodynamic data which suggest the patient will be subject to blackout
during posture changes. In terms of pressure head, the pressure head is higher when the phantom
is in bed rest position as oppose to upright position. The reason that the pressure is higher during
bed rest position is because the pump produces less work when gravity is negligible. The
pressure head is calculated using the density, gravity, and height. When the pump is working
against gravity the pressure is less as oppose to negligible gravity.
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Figure 4.3. Posture transition pressure cycles at.

Figure 4.3 present the transition pressure for several cases of stenosis. In Figure 4.3, it is shown
that for a normal case the maximum transition pressure is 120 mmHg (16 kPa) and for the
stenosis case presented earlier (42% stenosis), the pressure is 151 mmHg (20.1 kPa). For an
extremely severe case, the maximum transition pressure is 170 mmHg. Figure 4.3 is useful in
the sense that it provides insight of the magnitude of transition pressure that occurs for each
stenosis case. Data shown in 4.3 can provide useful information to interventionist that aim to
address early onset atherosclerosis and orthostatic hypotension cases prior to extreme stages of
stenosis.
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Figure 4.4. Pressure change versus percent stenosis.

A general conclusion from the data mentioned is that stage 1 hypertension occurs at 40%
stenosis and the onset of blackout occurs within this regime. The next section of the present
study presents a study on the transfer of dye in the cardiovascular phantom.

4.2 Cardiovascular Phantom Dye Mass Concentration Studies
In the present study, a dye mass concentration study was performed on the ascending
aorta of the experimental cardiovascular phantom. The transport of dye mass in the present
study is performed to simulate the transport of an injected medical drug (intravenous drug
delivery/intra-arterial drug delivery). Intravenous injection involves injecting the aqueous form
of a drug into a superficial vein or continuous infusion via a needle or a catheter placed in an
artery or deep vein. This is the only method of administration available for some drugs and is
chosen in emergency situations because of the onset of action is rapid following injection.
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Theoretically, none of the drug is lost, and smaller doses are required other than with other routes
of administration.

The rate of injection can be controlled for prolonged and continuous

administration. Intra-arterial involves direct injection into the arteries and is not a usual route for
therapeutic drug administration. Arterial puncture and injection of contrast material has been
carried out for angiography. Most of the intra-arterial injections or arterial perfusions via
catheters placed in the artery for regional chemotheratpy of some organs and limbs. Intra-arterial
drug delivers is mostly used for the treatment of malignant tumors of the brain. Although the
goal of the present study is centered towards cardiovascular disease and not cancer, dye transport
is important in cases of cardiovascular disease such as the erosion of a medical drug coating from
a stent, the deposition and transport of plaque in the cardiovascular system, and the transport of a
x-ray dye into the cardiovascular system to map out blood flow trajectory paths.
The present study determined the transit time of the dye front, the axial physiological
Peclet numbers, and the validity of using numerical experiments as a surrogate for experimental
setups. The physiological Peclet number provides information on convective and diffusive
dominance. As mentioned previously mentioned in Chapter 3, the dye mass concentration
methodology consists of illuminating a section of the tubing with a green LED light and filming
the time the dye front enters the illuminated area.

For the purpose of comparing the

experimental mass concentration dye transit times to numerical transit time plots for validity, a
digital cardiovascular phantom was constructed using the same CAD model used to construct the
experimental cardiovascular phantom for numerical analyses.
cardiovascular phantom is shown in Figure 4.5.

A schematic of the digital
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Compliance
Chamber

Outlet

Inlet

Figure 4.5. CAD schematic of the digital cardiovascular phantom.

During experimental observation, the illuminated section or region of interest (ROA) of the aorta
appears to be pure water at the time 0s through about 13s. At approximately 13s, the dye front
approaches the ROA around. For visual purposes, the zero mass concentration time was not
included in the mass concentration. Figure 4.6 provides a more accurate assessment of the
transit time of the dye front. From the time the dye front reaches the ROA, the trend of the graph
grows exponentially. The mass concentration is calculated using Eqn. from Chapter 3. The
digital cardiovascular phantom contained one inlet and one outlet and a mirrored boundary
condition was imposed to simulate a closed loop system. The drug material properties in the dye
trace study were set to have the same diffusive properties as a water-in-water solution to simulate
a liquid drug injection.

94

(a)

(b)

(c)

(d)

(e)

(f)

Figure 4.6. Photograph of LED illuminated aortic section for dye mass concentration analysis at:
0.0s (b) 12.58s, (c) 13.05s, (d) 13.67s, (e) 14.012s, and (f) 16.5s
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Figure 4.7 provides a plot of the mass concentration vs. time. From 0s until 4s the ROA
increases in concentration until it stabilizes at 4s throughout the duration of continuous injection.
Based on normal heart rate and bed rest conditions the transit time for the drug to reach the
descending aorta is 14s when including the time of injection. The physiological Peclet number is
calculated using equation 4.1:
Pe 

vh
D

Eqn. 4.1

Where h is the distance, v is the velocity and D is the diffusivity. The diffusivity of water is
approximately 1.6x10-9 m2/s. The maximum Peclet number (systole) is 20,000,000 whereas the
minimum Peclet number is 400,000 (diastole). The physiological Peclet number provides insight
on the balance of convection to diffusion.

CNumerical=0.0389t5-0.4158t4+1.6637t3-3.068t2+2.6423t-0.0685
R2=0.9948

Figure 4.7. Plot of mass concentration vs. transit time.
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Figure 4.8 provides a numerical vector and contour plot of the velocity at the section
where the numerical mass concentration profile was obtained. A plane was sliced in mid-section
of the descending aorta where the mass concentration measurements were obtained to view the
magnitude of velocity and provide an explanation of the monotonic behavior/trend in the plot.
Figure 4.8a provides a vector plot of the velocity at diastole of the cardiac cycle. The velocity is
scaled from 0 to 0.122 m/s in terms of radial velocity. From Figure 4.8a, the direction of the
flow points to the outward radial direction and the highest flow occurs in regions near the wall
which indicates flow reversal.

(a)

Velocity
(m/s)

(b)
Figure 4.8. Aorta cross-sectional view of: (a) velocity vectors (left) and velocity contour (right)
at diastole and (b) velocity vectors (left) and velocity contour (right) at systole.
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Also from Figure 4.8, the `highest velocity occurs at the peak and near the wall. Figure 4.9
provides a snapshot of the vorticity at the cross-section of the aorta. Vorticity is defined as the
magnitude of the spin of the fluid. An explanation of how vorticity is calculated is provided. The
derivation of the vorticity equation begins with the Navier-Stokes equations in vector form:



p

V  
 V  v     gy    2 V
t



Eqn. 4.2

By taking the curl of the Navier-Stokes equations, the vorticity equation can be obtained. In




detail and taking into account  u   , the following is obtained:
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Eqn. 4.3

The first term on the left side, for fixes reference frames, becomes:



V  
 

   V  
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 t

Eqn. 4.4

In the same manner the last term on the right side becomes:




  ( 2 V )   2 

Eqn 4.5

Applying the identity  s  0 , where s is a scalar, the pressure term cancels, provided that
the density is uniform
 p

      gy    0

 


Eqn 4.6



The inertia term V  V , can be rewritten as:
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Eqn 4.7
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Where V  V  V  V , and then the second term on the left side can be rewritten as:
2
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 2 

Eqn. 4.8

The vorticity equation can be obtained and written as:

D    
     V   2 
Dt 


Eqn. 4.9

From Figure 4.9 the highest amount of vorticity occurs during diastole, at which could be due to
the dampening of the flow. However, at both systole and diastole the highest vorticity occurs at
the wall, which indicated flow reversals. This explains the non-monotonic behavior in the mass
concentration profiles.

Vorticity (s-1)

(a)

(b)

Figure 4.9. Aorta cross-sectional view of vorticity contours at: (a) diastole and (b) systole.
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The experimental results have been compared to the experimental results for validation purposes.
The key take away from the dye trace study is the experimental and numerical results are within
3 percent agreement (0.3-1s and 1.7-2s) and that the monotonic behaviors of the mass
concentration profiles are due to flow reversals. The study above is a direct simulation of intraarterial injection where a catheter is placed in the artery. Figure 4.10 provides a contour plot at
discrete time intervals to provide an illustration of the drug trajectory path and transit time during
the cardiac cycle.
From Figure 4.10, the dye enters the ascending aorta through the aortic valve at time
t=0.0s. The flow appears to be purely convective. The parameter that describes the convective
dominance of the flow is the Peclet number. The Peclet number equation is described earlier in
Eqn 4.1. The minimum Peclet number for the flow is whereas the maximum is. The minimum
and maximum Peclet number is described by the peak of the cardiac cycle. From Figure 4.10,
after the dye enters the aorta, the dye reaches the descending aorta around 4.5s and then reaches
the femoral section around 11.6s. The dye does not start traveling up the common carotid artery
until around 29.6s. Ultimately, the flow of the dye is focused from the aorta to the femoral
section. The flow diverts later into the branching networks after flow has reached the femoral
sections. This is important because if a drug is injected into the cardiovascular system and has a
specific target sight, it is important to know where the drug will go and how much of that drug
will divert. Also as shown in Figure 4.10, the time that it takes for the dye to enter the upper
(cranial) part of the phantom is much longer than it take for the dye to travel around the aorta to
the descending aorta. This is due to the centripetal forces that occur around the bend of the aorta.
These forces, force the dye to accelerate around the aorta curve which creates the unsteadiness as
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shown in the monotonic trend of the mass concentration curve and the rapid transport of dye to
the descending aorta.

(a)

(b)

(c)

(d)

(e)

(f)

Mass Concentration
(dimensionless)

(g)

(h)

Figure 4.10. Dye mass concentration at time: (a) t=1.75s (b) t=2.1s, (c) t=4.5s (d) t=11.6s (e)
t=15.1s (f) t=29.6s (g) t=94.6s, and (h) t=150s.
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Clinical studies may find studies such as these useful to find approximate time frames of drug
delivery and the trajectory path of the drug from the point of injection. Due to the fact that in the
cardiovascular system there are many curves and bends that the drug can take route to, clinicians
may need to know where exactly the drug may go after injection. Another study that may find
this useful is medical implants that disperse drugs into the arterial system. The next section
presents a study on the aorta and carotid artery using particle imaging velocimety (PIV).

4.3 Aorta and Carotid Artery PIV Studies
The present study also examines the hemodynamic parameters of flow in the aorta and
carotid artery during rest cycle using PIV.

The aorta and carotid artery geometry was

reconstructed using the same process outlined in Chapter 3. The geometry used to construct the
aorta and carotid artery part of the phantom is from a 28 year old patient. The purpose of this
section is to address the flow patterns and magnitude of wall shear stress present in the aortic
section during the rest state cycle. The carotid artery is branched from the CCA branch of the
aorta. Although the geometry used is from a 28 year old patient, the geometry can be modified
to simulate diseased and non-diseased cases as shown in the previous section. The aortic section
of the cardiovascular system is considered to be the main branch/vessel responsible for
delivering blood to the entire cardiovascular system. In most cases, the aorta is the first section
that experiences a buildup of plaque and/or rupture. The buildup of plaque in any artery reduces
blood flow throughout the system which in turns reduces the level of oxygenated blood to the
brain. Aortic rupture or aneurysm is also another effect of plaque buildup. Aortic aneurysm is a
pathological enlargement of the aorta area taking the fusiform shape and may extend to
neighboring arteries.

The mortality of this pathology is high in elderly patients (15% for
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ruptured aneurysms), and the current standard of determining rupture risk is based on
anteposterior diameter. The high increase of wall shear stress also plays an important role in the
health of arteries and cardiovascular system. High levels of wall shear can lead to blood cell
lysising or endothelial rupturing. Extremely low levels of wall shear can lead to endothelial cell
death. The study begins with flow in the carotid artery. Figure 4.11 present an image of
particulates dispersed in the flow through the carotid artery for PIV analysis. The arterial model
shown is a glass model and the analyses are conducted from a single unit rather than from a full
cardiovascular system.

Figure 4.11. Photograph of particulates dispersed in carotid artery flow field.

Figure 4.12 presents the velocity contours at 3.2 s and 3.5 s. As shown in Figure 4.12, the
highest magnitude of velocity is present in the bifurcating region of the CCA. There are also
period where the flow dampens and accelerates which is due to the fluctuations and harmonics
produced by the heart valve.
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(a)

(b)
Figure 4.12. PIV carotid artery velocity contour plots at time: (a) 3.2 and (b) 3.5s

Figure 4.12 presents the velocity waveforms of the carotid artery during rest state cycle at 3.2
and 3.5s. Figure 4.12a presents the velocity waveform at 3.2s and Figure 4.12b at 3.5s. The
centerline velocity at 3.2s is 0.0045 and 0.004 at 3.5s.
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(a)

(b)
Figure 4.13. Carotid artery velocity waveforms extracted from PIV experiments at: (a) t=3.2s
and (b) t=3.5s.

As shown in both Figure 4.13a and 4.13b, the no slip condition is not captured due to the glare in
the wall from the PIV lighting. The hemodynamic parametric results of the aortic section of the
cardiovascular phantom are also discussed. Figure 4.14 shows a velocity contour and vector plot
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of the aorta. The contour plots contain a region of interest area (ROA) that focuses on the area
after the arch which is the descending aorta. The scale of the velocity magnitude is from 0 to 0.9
m/s with the color scale ranging from blue being 0 m/s and red being 0.9 m/s. As shown in
Figure 4.14, the velocity magnitude distribution/profile appears to be uneven about the centerline
of the aorta.

This profile continues further down from the ROA site.

However when

approaching the arch area near the aortic valve, the largest magnitude of velocity occurs near the
centerline. The largest magnitude of velocity occurs near the outer wall of the aorta near the
descending aorta region. Although there are areas of high velocity approaching the wall, the noslip condition is captured at the outer wall. In Figure 4.12 highlights this phenomenon more
clearly.
Figure 4.15 contains a plot of the velocity profile at one location of the ROA site at
different time intervals (T). The velocity profiles shown in Figure 4.15 highlight the change in
velocity as a function of time. The profiles confirm the uneven distribution of velocity across the
diameter of the ROA site. At time T= 3s, the velocity reaches systole which is the peak velocity
in the cardiac cycle. The maximum velocity at systole appears to be around 0.5 m/s. However
when looking at the velocity contours, the contour highlights sections where the velocity reaches
a maximum around 0.9 m/s. The velocity profiles were extracted midway of the ROA site.
From the velocity profiles and the velocity contours, a general conclusion can be made that that
the velocity profile is not constant along the axial direction of the aorta. This in part could be
due to the curves and bends in the aorta that produces vortices and unsteadiness in the trajectory
of the flow.
pump/heart.

This could also be due to the dampening/fluctuations of harmonic from the
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(a)

Velocity
(m/s)
(b)
Figure 4.14. PIV velocity contours at: (a) 0.1s and (b) 0.5s
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(a)

(b)
Figure 4.15. Plot of velocity profile for: (a) different time steps and (b) profile and velocity
equation at time T=0.3s.
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The velocity contours are also useful because it provides information about the transport of
blood. The artery itself contains a lining of cells in the interior core in which the blood is in
contact with. The blood feeds nutrients to these cells. It has been hypothesized that the wall
shear stress promotes or deters cell growth and maintenance. In actuality, the transport of blood
to the artery wall provides the necessary nutrients to the cell lining. From the contour plots, one
can see that high levels of transport take place near the wall. Figure 4.16 provides a plot of
diameter vs. wall shear stress at systole (time T=3s). The wall shear stress was derived from the
velocity distribution. The equation for calculating the wall shear stress is shown below:

 

u
r

Eqn. 4.10

The derivative of the velocity distribution was taken and multiplied by the viscosity of the
working fluid and fitted using the diameter of the pipe. A plot of this is shown below in Figure
4.16.

Figure 4.16. Diameter vs. wall shear stress at time T=0.3s.
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As shown in Figure 4.16, the minimum wall shear takes place at the centerline which indicates
that the gradient is near zero at the centerline. The highest wall shear takes place at the wall.
The normal range of wall shear stress in the arteries ranges from 1-12 Pa. The highest wall shear
stress occurs during systole and falls within the range of 1-12 Pa. The highest wall shear
observed is around 11.8 Pa. Information such as this is useful for predicting cell death, rupture,
and buildup of plaque.

Compliance is another important parameter in the analysis of

cardiovascular disease.
Compliance in the aorta is thought to have a strong role in the progression of
cardiovascular diseases. In the present study, compliance is not calculated directly. However
the change in diameter is used determine the overall compliant nature of the arterial wall. Figure
4.17 provides a plot of the diameter of the aorta as a function of time during the rest state cardiac
cycle. The relaxed diameter (diameter of the aorta with the pump off) is 32 mm. The maximum
diameter 34 mm (systole) is and the minimum diameter is 32.9 mm (diastole). The maximum
change is diameter is 2 mm and the minimum diameter change is 0.9 mm.

The percent

difference in diameter change is calculated below using Equation 4.3:
%d 

d1  d 2
 d1  d 2 


 2 

Eqn. 4.11

Using equation 4.11, the maximum percent change in diameter is 6% and the minimum is 2.7%.
The change in diameter in this case is important because it provides insight on the possibility of
aneurysm/rupture. In most cases, the aorta ruptures after severe hardening but can also rupture
during cyclic expansion. Also it is evident that the change in diameter promotes additional
perturbations in the flow which are mentioned earlier. This is important in cases where CFD is
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used for prediction of flow patterns and profiles. Most CFD studies use rigid models that don‟t
capture the full effect of fluid structure interaction effects.

Figure 4.17. Diameter vs. Time for the aorta during rest state cycle.

4.4 Drug Eluting Stent Drug Mass Concentration Studies
In the present study, a drug eluting stent (DES) diffusion time analysis study was
conducted. The DES simulations for the present study compare the intravascular drug delivery
from a drug coated stent with its coating diffused into the arterial wall. The model developed for
drug delivery, the drug internalization rate, interstitial fluid flow, and strut embedment are
investigated for their impact on the drug transport and distribution. In the model simulations, a
half strut-embedment is considered and the internalization rate and the interstitial fluid flow
velocity are both set to zero, for the purpose of comparing with previous modeling work and
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examining the impact of individual model factors. As mentioned previously, the plasma flow
which is normal to the lumen flow is set to 1E-8m/s. The no-slip condition is specified at the
wall. Figure 4.18 shows the velocity contour of the plasma flow into the arterial wall.

Velocity (m/s)
Figure 4.18. Velocity contour of plasma flow into the artery wall.

The simulation results are reported for unbound drug release profiles in the arterial wall.
Specifically, the average drug concentration in the arterial wall is defined as the spatial average
of the drug. The three means of characterizing the drug delivery process are consistent with
other modeling works, while contributing to the possibility for potential comparison with future
experimental measurements. In the simulation comparison, the total drug release is achieved in
limited drug dissipation, not the plasma flow from the arterial wall. The zero flux boundary
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condition is also applied to the left and right boundaries based on symmetry, and at the coatingstrut interface.

At the coating-arterial wall interface, an equal flux constraint and equal

concentration partitioning are applied. For the initial conditions the drug is initially uniformly
distributed into the arterial wall as shown in Figure 4.19a and Figure 4.19b.
In observing drug release profiles, from the time of deployment up until the first five days
when the degradation and erosion appear to be minor. In the simulation comparison, the drug
concentration is around 95% on day 115. Corresponding to the difference in the release profiles,
the average drug concentrations in the arterial wall starts off with similar levels for the released
drug. The drug concentrations gradients appear very early in the case around day five. The drug
level increases as a result of accelerated drug release by degradation and erosion in the coating.
The fast increase in drug concentration is contributed by the fast drug clearance rate at the
interface. In each case, the trends of concentration evolution for the free drug are highly
identical, as a result of the fast reversible binding process in comparison to drug diffusion.
The drug distribution is close to uniform in the circumferential direction (x-direction) as
shown in Figure 4.19 c, d, and e, whereas in the transmural (z-direction) direction a gradient is
clearly observed closer to the perivascular interface. Upon close inspection, minor asymmetries
in the concentration profiles can be observed in Figure 4.19 e, f, g, and h. This is not numerical
error but occurs because of slight differences in the volume of tissue proximal and distal to the
stent after deployment.

The stent was centered with respect to the axial direction before

deployment. This symmetry was broken during deployment because of stent foreshortening.
While these asymmetries are noticeable, they are not significant enough to affect the
interpretation of the parametric studies. It is even more visible in Figure 4.20. A measurement
line was drawn on the arterial wall in the longitudinal direction to capture the effects of drug
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concentration of the wall. The better uniformity in the circumferential direction is expected with
the aniostopic drug diffusivity which results in fast drug diffusion in the circumferential
direction. The observed arterial drug distribution patterns appear to have nonlinear trends in
drug concentration distributions from.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Mass Concentration
(dimensionless)

Figure 4.19. (a) 5 days, (b) 15 days, (c) 25 days, (d) 35 days, (e) 45 days, (f) 55 days, (g) 65 days, and
(h) 115 days.
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Figure 4.20. Drug concentration vs. distance for DES analysis.

Figure 4.20 reveal how the deposition patterns tend to follow the pattern of the stent struts and
how the drug is able to penetrate deep into the vessel wall. Figure 4.20 also shows a trend that
shows that the concentration profile from strut to strut becomes more steep and linear as time
progresses. The profile becomes more linear near day 45. For this particular case, the drug used
diffuses completely around 3.5 months. A drug release profile study was also conducted on the
entire cardiovascular system using CFD.

4.5 Evaluation of the Effect of Patient-Specific Geometry on Hemodynamic Flow
In the present work, CFD analyses were performed on a simplified carotid bifurcation
arterial geometry and two patient-specific carotid bifurcation arterial geometries.

The

geometries are discretized and used as computational domains. For blood flow simulations, the
conventional assumptions: flow in the carotid bifurcation artery is Newtonian, laminar,
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incompressible, and isotropic are implemented. By these assumptions, blood can be modeled by
the incompressible Navier-Stokes equations with blood density specified as 1060 kg/m3 and the
corresponding dynamic viscosity as 0.0035 kg/m s. The commercial software GambitTM was
used for geometric meshing and FLUENTTM was used to solve the Navier-Stokes equations in
the finite volume formulation. Equation 4.12 is used to solve the fluid flow equations in the
finite volume form.
 v

 v v   p   2
 t




Two CFD analyses were conducted.

Eqn. 4.12
The first analysis was conducted with a simplified

sinusoidal velocity waveform which simulates a rest-state cycle.

The rest-state cycle is

implemented as a boundary condition at the inlet of the CCA branch of each arterial geometry.
The first analysis compares the magnitude of hemodynamic parameters in a simplified arterial
geometry and two patient-specific geometries and compares the efficacy of modeling simplified
geometries as opposed to patient-specific geometries. The second analysis implements two
patient-specific velocity waveforms, one at rest-state and exercise and compares the magnitudes
of hemodynamic parameters at both rest state and exercise. The second analysis also compares
the efficacy of modeling patient-specific geometries over simplified geometries.

For both

analyses, the ICA and ECA outlets were modeled as pressure outlets at 12 kPa (90mmHg). A
grid independent study was conducted prior to assessing the hemodynamic results. Grid meshing
levels were performed at three levels: coarse (104,406), coarse (143,948) and medium (233,045)
and it was determined when evaluating wall shear stress and pressure that the CFD results were
no longer depending on the size of the mesh at 233,046 cells.
independent study data.

Table 4.3 show the grid
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In comparison of the velocity at the ICA for geometric models, a 0.21% difference in
velocity was observed for a grid independence study. For numerical solutions, the velocity
coupling solving technique was implemented. The WSS vectors are predicted on fluid domain
surfaces that represent the interface boundary between the fluid and the neighboring tissue. For
analyses, the WSS are calculated using Eqn 4.13. Velocity is monitored at the CCA, ECA, and
ICA and vorticity is calculated at the sinus bulb. CTA images of stenosed carotid bifurcations
were taken from a 50 and 66 year old male and were processed in Solidworks. Figure 4.21
presents a schematic diagram of the Solidworks processing methodology. The parametric data of
the patient-specific carotid artery geometries (CA-1) and (CA-2) is provided in Table 4.3.
Simulations and analyses were performed for three geometries, the simplified carotid bifurcation
arterial geometry (SA-1) and two patient-specific carotid bifurcation arterial geometries (CA-1)
and (CA-2). For the second analysis, SA-1 geometry is replaced with a second simplified
geometry that resembles a patient-specific geometry. The simplified geometry used in the
second analysis contains the same diameter for the CCA, ICA, and ECA as in patient-specific
geometry (CA-1). The difference however is that the diameters are constant on all branches as
opposed to a variation in diameter along the centerline of the branch.
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Table 4.3
Patient-specific carotid bifurcation geometry parametric data.

Parameters

Carotid Bifurcation Model
Model CA-1

Model CA-2

Age

66 year(s)

60 year(s)

Sex

Male

Male

Side

Left

Left

Basis of disease

Atherosclerosis

Atherosclerosis

Direct cause of death

IMA

Aneurysm

Diameter of CCA

7.475 mm

7.725 mm

Diameter of ECA

5.35 mm

5.0 mm

Diameter of ICA

8.0 mm

6.075 mm

Diameter of Carotid Sinus

5.7 mm

7.6 mm

Branch angle between CCA
and ICA

45 degrees

29.5 degrees

Branch angle between CCA
and ECA

42 degrees

21 degrees
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Figure 4.21. (a) CTA scan point cloud image, (b) 3D spline surface generation, (c) lofted and
boundary base solid part model of the carotid bifurcation, (d) meshed postprocessed carotid artery geometry.

Figure 4.22 shows a CAD drawing of both arterial models. The location of the sinus bulb
was monitored for calculating WSS and vorticity as a function of time. Previous studies have
suggested that vortictity measurements are predictors of flow disturbances which in turn
produces high levels of shear and promotes the onset of shear licensing and or rupture of the
vessel lining. Velocity has been calculated throughout the CCA, ECA, and ICA of the simplified
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arterial geometry and patient-specific arterial geometries at any point in time. Figure 4.23 shows
the velocity waveform monitored at the ICA outflow of the three geometries at time 0s to 3s. At
the beginning of the cycle, the blood flow rate starts increasing and reaches a maximum level
around 0.45s and then decreases to the lowest level at 1.3s. Figures 4.23 present a plot of the
vorticity vs. time for the SA-1, CA-1, and CA-2 geometries.

Figure 4.22. CAD drawing of CA-1 and CA-2 bifurcation CFD geometries.
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(a)

(b)

(c)
Figure 4.23. Plot of sinus vorticity vs. time for the CA-2 patient-specific geometry and
the simplified arterial geometry SA-1.
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Figure 4.24 shows the axial velocity contours of the sinus at time 0.5s (systole), and Figure 4.25
shows the axial velocity contours of the sinus at time 1.0s (diastole).

(a)

(b)

Velocity (m/s)

(c)
Figure 4.24. Axial velocity contour at time T=0.5s (systole), for (a) SA-1, (b) CA-1, and (c) CA-2.
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(a)

(b)

Velocity (m/s)
(c)
Figure 4.25. Axial velocity contour at time T=1.0s (diastole), for (a) SA-1, (b) CA-1, and (c)
CA-2.
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The negative velocity indicates flow reversal zones. As shown in Figures 4.24 and 4.25, the
maximum flow reversal is observed in the patient-specific geometry models. For the patientspecific geometries, it was also observed that the axial velocity is the highest at the region
upstream of the ICA and downstream of the sinus near the CCA. Regions of flow reversal
formed near the sinus wall are due to the rapid changes in the flow rate, flow viscosity and the
curvature of the sinus. Within these zones, blood flows in the direction opposite to the mean
flow increasing the probability of plaque deposition.
For the patient-specific geometries, the velocity gradients near the stenosis are much
higher than those near the sinus. The velocity at the sinus becomes negative and indicates flow
reversal and very low WSS. WSS is an important factor in the progression and initiation of
atherosclerosis. For the simplified geometry, there is a small region of velocity increase at the
stenosis, and very little flow downstream of the stenosis to the ICA outlet. The major increase of
velocity in the simplified geometry is experienced in the ECA branch of the artery. Figure 4.24
shows the WSS contour for systole (peak velocity) for the simplified arterial model and patientspecific geometries. Regions with WSS less than 0.4 Pa are susceptible to atherosclerosis. In the
wall shear stress contours provided in Figure 4.24, it is shown that the maximum WSS
experienced is 16.3 Pa. The maximum WSS is shown at the ICA stenosed region of SA-1 and at
the stenosis and bifurcating region of CA-1.
A general conclusion from these WSS patterns is that the sinus bulb is the most
atheroprone site where higher values of WSS appear at the bifurcation apex and final ends of the
ECA and ICA, which have a smaller diameter. There is a stagnation point at the apex because
shear directions at its sides are different (granting that the magnitude of the shear would be
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(a)

(b)

Wall shear
stress (Pa)
(c)
Figure 4.26. WSS contour at time T=0.5s (systole), for (a) SA-1, (b) CA-1, and (c) CA-2.
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relatively high). The stagnation point is the place of plaque buildup. Another point is that, in
general, realistic geometries have higher values of WSS and the atheroprone site in the sinus
bulb is smaller. When considering WSS, the magnitude of the wall shear is a function of the
geometry of the arterial vessel. This works proves that when studying hemodynamics of the
arterial vasculature, specifically the carotid bifurcation artery for diagnostic purposes, it is
important to have patient-specific parametric data for the carotid bifurcation vessel to be
analyzed.

In addition to geometry comparisons in the efforts of comparing hemodynamic

parametric magnitudes, a comparison was also made in studying the effect of patient-specific
waveform on hemodynamic parameters.
Pulsatile blood flow during rest-state and exercise were simulated for the three carotid
bifurcation arterial geometries, the simplified carotid bifurcation arterial geometry and two
patient-specific arterial geometries (CA-1) and (CA-2). As mentioned earlier, SA-1 is replaced
with a more realistic geometry. The new SA-1 contains a constant diameter along the centerline
of each branch of the artery. From this point, the simplified carotid artery will be referred to as
artery “S”, the patient specific artery CA-1 will be referred to as artery “A”, and CA-2 as artery
“B”. The volumetric flow rate waveforms used in the present study are aortic artery blood flow
rate waveforms during rest-state and exercise.

For each case evaluation, fully-developed

velocity boundary conditions were imposed at the inlet during steady-state calculations and were
iterated until the solution converged and a feasible hemodynamic solution was obtained. After
the steady-state calculation converged and feasible hemodynamic solutions were observed, the
solver was then switched to transient solver for rest-state and exercise calculations. Volumetric
flow rate were calculated throughout the ECA and ICA of the simplified arterial geometry and
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patient-specific geometries for two cardiac cycles. Figure 4.27 presents the volumetric flow
waveform monitored for two cardiac cycles.

(a)

(b)
Figure 4.27. Volumetric flow rate waveform during: (a) rest-state, and (b) during exercise.
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As shown in Figure 4.27a during the rest cycle, at the beginning of the cycle, the blood
volumetric flow rate accelerates and reaches a maximum level around 11.2 ml/s and then
decreases and to 1.7 ml/s and then accelerates to 4.2 ml/s decelerates again and remains constant
at 3.8 ml/s until the cycles starts over again at 1s. When comparing hemodynamics during the
rest-state cycle, for Carotid Artery A, the ICA branch which supplies blood to the brain reaches a
maximum blood flow rate of 2 ml/s while the ECA reaches a maximum flow rate of 7.8 ml/s.
Similarly, for Carotid Artery B, the ICA branch reaches a maximum blood flow rate of 2.2 ml/s
while the ECA reaches a maximum flow rate of 9.8 ml/s. As shown in Figure 4.27b, during
exercise, for Carotid Artery A, the ICA branch which supplies blood to the brain reaches a
maximum blood flow rate of 3 ml/s while the ECA reaches a maximum flow rate of 11.8 ml/s.
Correspondingly, for Carotid Artery B, the ICA branch reaches a maximum blood flow rate of 4
ml/s while the ECA reaches a maximum flow rate of 14.8 ml/s. When analyzing volumetric flow
rate for rest-state and exercise, the volumetric flow rate on all outlets for all three arteries
increases by a magnitude of 1.5 when switching from rest-state to exercise.
Figure 4.28 presents the average weighted WSS contours during rest-state and exercise.
The normal range of WSS in the arteries of a healthy human being is 7-12 Pa during normal
activity. The WSS contour snapshots are taken at the highest volumetric flow peak during the
cardiac cycle (systole). As shown in Figure 4.28, the simplified carotid bifurcation arterial
geometry, denoted at the top of the snapshot by the bold red “s” in a square bracket, appears to
have 0 WSS on the ICA branch during systole of the rest-state cycle. However, during exercise,
the average weighted WSS on the ICA branch increases to 0.65 Pa. The highest WSS occurs on
the CCA branch and ECA branch of the simplified artery.

During rest-state the average
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weighted WSS on the CCA and ICA is 1.95 Pa, while during exercise on the ECA branch the
WSS increases to 9.75 Pa.

Figure 4.28. WSS contours at systole during: (a) rest-state and exercise.

However for the patient-specific carotid bifurcation arterial geometry A, there is 0 WSS on the
sinus bulb during rest-state and exercise. The value of 0 WSS on the sinus bulb indicates that
there is no mass transport of blood on the sinus bulb region which also indicates that the sinus
bulb will experience endothelial cell death and rupture if there is no transport of blood in that
region. From Figure 4.28, the highest WSS that occurs in the patient-specific geometry A during
both cycles is 13 Pa and occurs on the ECA branch which feeds blood to the face. For patient-
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specific geometry B, the sinus bulb experiences a WSS magnitude of 3.32 Pa during rest and an
average of 5.2 Pa during exercise.

(a)

(b)
Figure 4.29. Plot of WSS vs. time systole during: (a) rest-state and exercise.
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However as shown in Figure 4.29, the ECA branch of Carotid B reaches a maximum average
weighted WSS of 4 Pa during exercise, while the ICA reaches a maximum of 9 Pa. Figure 4.29
also shows that Geometry A experiences the highest peak of WSS of 17 Pa on the ECA branch.
This is due to the highest magnitude of flow taking place on the ECA branch. The crosssectional area of the ICA branch on geometry A is much smaller than the ECA, and due to
continuity, the flow is accelerated on the ECA branch which has a larger cross-sectional area.
Figure 4.30 presents the average weighted NS contours during rest-state and exercise.

Figure 4.30. NS contours at systole during: (a) rest-state and exercise.
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The NS contour snapshots are also taken at systole. As shown in Figure 4.30, the simplified
carotid bifurcation arterial geometry, experiences an equalized balance of NS on all branches of
the artery during rest-state. The average weighted NS is 0.72 Pa on the CCA, ECA, and ICA.
However on the bifurcation region near the ECA, a small region experiences a slightly high NS
of 1.61 Pa. However, during exercise, the average weighted NS increases from the bifurcation
region throughout the ECA on the simplified geometry during exercise. The same trend occurs
on Geometry B; however the magnitude on the ICA and CCA is 2.5 Pa with a small region on
the sinus of –1.95 Pa. The negative sign indicates a compressive force, whereas the positive NS
values indicate tensile. The magnitude of NS on the ECA has a concentrated region of NS of
around 8.74 Pa and diminished to 4.28 Pa throughout the ECA. The same can be found true on
Geometry B, the magnitude. The average NS on all branches of Geometry B is 2.5 with a small
region on the ICA branch experiencing a compressive force of -1.95 Pa. The NS forces are
important in analyzing the forces that may produce rupture in atheroprone areas or in a more
generalized sense, areas that are experiencing endothelial cell death and thinning of the vessel
lining.
As shown in Figure 4.31, vorticity in the arteries has the same trend as WSS. For the
simplified case minimum vorticity (7.49 s-1) takes place on the ICA, whereas on the CCA and
ICA branch a magnitude of 1030 s-1 is experienced. For Geometry B, the least amount of
vorticity is seen on the sinus bulb region whereas the highest magnitude takes place on the ECA
branch. The least amount of vorticity occurring on the sinus bulb region is due to the lack of
mass transport on the wall of the sinus. The maximum vorticity is due to continuity, the
restriction of flow taking place on the ICA branch causes an acceleration of blood flow on the
ECA branch and increase of vorticity. However for Geometry B, there is equalized vorticity on
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the CCA branch throughout the ECA; however the highest magnitude of voracity is experience
on the ICA branch. WSS, NS, and vorticity are vital measurements for assessing hemodynamic
factors. In the present study, these three measures have been used to verify the role of age,

Figure 4.31. Vorticity contours at systole during: (a) rest-state and exercise.

gender, and geometry on hemodynamic flow patterns. The simplified geometry in the present
study has proven to provide an exaggeration of hemodynamic parameters during analyses. The
simplification of arterial vessel geometry yields hemodynamic results that cannot be substituted
and relied on for real life measurements for male and female patients. For instance, for all cases
of WSS, NS, and vorticity, the simplified geometry provided 0 WSS measurements on the ICA
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branch which indicates no mass transport and for NS, equalized magnitudes of NS measurements
on all branches with the exception of the bifurcation region.

Geometry A and B yields

meaningful results in the sense that the hemodynamic results are different in the case of age,
gender, and arterial vessel geometry. The hemodynamic trends are different in the case of
evaluating patient-specific geometry, thus confirming the effect of age, gender, and geometry on
hemodynamics. Also the case of evaluating hemodynamics during rest-state and exercise has
provided meaningful results in the sense that the magnitude of WSS during exercise provides a
measure of the risk of WSS licensing of red blood cells, and NS provides a magnitude range for
the risk of vessel rupture.

4.6 Evaluation of the Effect of Stent Design on Hemodynamic Flow
In the present study, the hemodynamic features of a simplified vs. patient-specific stented
arteries are compared.

In addition to simplified and patient-specific stented arteries, three

different stent designs are assessed. Differences in WSS, normal (radial) stresses, and vorticity
(de-mixing) are reported which confirms the effect of stent design, specifically strut positioning
bridge pattern design on hemodynamics. Eqn. 4.13 is used to calculate the normal stresses.
Physiological WSS in an artery is normally within a range from 1 Pa to 7 Pa (Malek 1999).
However, WSS that exceed this range and occur at localizes sites can influence dislodging and/or
migration of the stent. Figure 4.32 present the WSS contour plots of the simplified stented cores
for stent designs A, B, and C. The highest WSS values were found to occur over the center of
the curved region within the surface of the stent struts as shown in Figure 4.32.

 xx  2 

u
x

Eqn. 4.13
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Wall Shear
Stress (Pa)

Figure 4.32. Wall shear stress contour for stent designs A,B, and C.
Also Figure 4.32 shows the regions of low WSS before and after each strut. For the simplified
stented core and patient-specific stented core CFD analyses, WSS follows a trend for all stents
except for regions between the strut and bridge, as shown in Figure 4.32. For stent designs A
and C, a larger area of arterial tissue is exposed to relatively low WSS (light blue area in Figure
4.32 between stent struts), compared to Stent Design B. For Stent Design B, the arterial tissue
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wall area within the first unit cell experiences a relatively high WSS compared to the area around
the stent struts. For Stent Designs A and C, areas of low WSS occur at transitions between the
core and stent and were most pronounced where the strut orientation was orthogonal to the
direction of blood flow. For all three stents, WSS had a high value proximal to the stent struts
and a relatively lower value in the area occupied or exposed to neighboring arterial wall tissue.
Figure 4.33a shows the point averaged normalized WSS patterns for all stents averaged
over the entire stent wall core impression for the simplified stented cores and the patient-specific
arterial stented cores. Figures 4.33a and 4.33b show the scaled WSS and radial stress results of
the incoming fluid. The stresses are scaled with the dynamic pressure “ρV2 ”and the cycle time
is scaled with the total time, t=3 sec. As shown in Figure 4.33a, the maximum normalized WSS
for all stents occur at the point of maximum inlet velocity (systole) and the minimum normalized
WSS occurs at the minimum inlet velocity (diastole). When comparing the normalized WSS
results for the simplified arterial stented core results compared to the patient-specific stented core
results, the percent difference of the point averaged normalized WSS for Stent Design A is
44.7%, 44.4% for Stent Design B, 55.8% for Stent Design C, and 25.65% for the Simplified
Stent Design.
Maximum WSS within the stented region for all stent designs are localized within the
curved regions of the struts. Figure 4.33b shows the normalized point averaged radial stress
trend for all stents averaged over the entire stent wall impression for the simplified stented cores
and the patient-specific arterial stented cores. When comparing the normalized radial stress
results for the patient-specific arterial stented cores compared to the simplified arterial stented
cores, the percent difference in results for all stent designs exceed 98.3%. Figure 4.34 present
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plots of the distributions of normalized WSS as a function of normalized strut distance within the
unit cell of each stent design.

Figure 4.33. Plot of: (a) normalized wall shear stress vs. normalized time and (b) normalized
radial stress vs. normalized time.

The distance is scaled with the total distance from strut to strut (x*=x/L). From Figure
4.34a and 4.34b, the trend of WSS within the area where the tissue is exposed to the blood has a
threshold region of minimum WSS. The threshold of minimum WSS may be attributed to the
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large area of tissue exposure which minimizes flow disturbance and also minimizes flow
resistance. In Figure 4.34c, the maximum WSS occurs in the unit cell area where the tissue is
exposed to blood flow which is due to the minimum area that exists between struts for stent
design C. Also stent design C has more struts compared to stent designs A and B, which
influence flow disturbance and WSS. A general conclusion that can be drawn from these
analyses is that large arterial tissue exposure within the stent unit cell experiences a lower WSS
compared to stents with small arterial tissue exposure.

Figure 4.34. Plot of normalized wall shear stress vs. normalized strut distance for (a) stent design
A and simplified stented core, (b) stent design B and simplified stented core, and
stent design C and simplified stented core.
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The flow distributions and WSS in larger arterial tissue exposure minimize due to the
absence of stent struts. Figure 4.35 present plots of distributions of normalized radial stress as a
function of normalized strut distance within the unit cell of each stent design. The trend of
increasing stress with smaller arterial tissue exposure is observed in the results presented in
Figure 4.35.

Figure 4.35. Plot of normalized radial stress vs. normalized strut distance for: (a) stent design A,
(b) stent design B, and (c) stent design C.
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When comparing the magnitudes of WSS and radial stress, the radial stresses that occur in both
the simplified stent arterial cores and patient-specific arterial stented cores are much smaller
compared to WSS and can be neglected. As shown previously in Figures 4.34 and 4.35, the
presence of a stent inside the arterial vessel gives rise to flow resistance and flow recirculation
(vorticity). Vorticity is defined as the spin or rotation of a fluid. Vorticity is an important
parameter in accessing hemodynamic factors because the magnitude of vorticity influences the
separation of blood constituents. Vorticity can be defined as the magnitude of de-mixing as it
pertains to hemodynamics. Blood is a heterogeneous mixture of various substances and the
magnitude of vorticity in stented arteries influences flow alteration and may cause acute
pathobiological responses. As mentioned previously, vorticity has been a major predictor of wall
shear disturbance and vessel rupture.
Figure 4.36 shows plots of the point averaged axial vorticity patterns for all stents
averaged over the entire stent wall core impression for the simplified stented cores and the
patient-specific arterial stented cores for the entire cardiac cycle. Figure 4.36a shows that the
highest magnitude of flow reversal (de-mixing) exists in Stent Design C, followed by Stent
Design A, the Simplified Stent Design, and Stent Design B. Figure 4.36b shows that the highest
magnitude of flow reversal exists in Stent Design A, followed by the Simplified Stent Design,
Stent Design C, and lastly Stent Design B. Figures 4.36a and 4.36b, show that the hemodynamic
behavior of the flow of a stented vessel is not only a function of the stent geometry, but the
upstream geometry before the entrance of the stent is important in modeling blood flow in a
stented vessel.
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Figure 4.36. Plot of axial vorticity vs. flow time.

Figure 4.37 shows the magnitude of recirculation that occurs between the struts of all stented
cores. The magnitude of recirculation varies with distance from strut to strut. For example, in
Figure 4.37a, Stent Design A has a vorticity magnitude of 650 s-1 which then changes direction
and magnitude to 620 s-1 and then minimizes to 198 s-1 before stabilizing to a vorticity magnitude
around 90 s-1. Recirculation zones in the cross-flow direction are observed for all stent designs
close to the arterial wall. Recirculating flow may be caused by the bridge connectors that
protrude into the space between the struts. It is important to note that the magnitude of vorticity
is different for each stent design. Also as shown in Figure 4.37, the magnitude of vorticity varies
with the geometry of the arterial core upstream of the stented region entrance. WSS and radial
stresses is a function of stent design, and vorticity is also a function of both stent design and the
stented core geometry.
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(a)

(b)

(c)
Figure 4.37. Axial vorticity vs. strut distance.
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4.7 Digital Cardiovascular Phantom Hemodynamic Results
In the present study a simple analysis was conducted to analyze the levels of wall shear
stress and normal stress that are present in the arteries of the full digital cardiovascular system.
Thus far, all of the hemodynamic parameters analyzed such as normal stress, wall shear stress,
and vorticity in the arteries via CFD have been analyzed in systems whereby the artery analyzed
is a single unit (an artery that is not connected with its neighboring constituent arteries). The
present study addresses the magnitude of stresses found in the arterial system during a normal
cardiac cycle. The digital cardiovascular system is the same model that was used earlier in the
dye concentration analyses. The analysis discussed here consists of a rest state cycle analysis
and static posture study.
Figure 4.38 present the wall shear stress contours for the digital cardiovascular phantom.
The contours present the wall shear magnitudes at different times during the cardiac cycle.
Figure 4.38a present the wall shear stress contour at diastole and Figure 4.38b present the wall
shear stress contour at systole. The contours are broken into sections due to regions of varying
wall shear stress in the digital cardiovascular system. The magnitude of the wall shear stress is
higher in the mid-section of the phantom (aortic section) as appose to the upper level (cerebral).
The same is true for normal stress. As mentioned earlier in the preceding sections, the range of
wall shear stress in the arterial system ranges from 1-12 Pa during normal cardiac cycle.
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(a)

(b)

Figure 4.38. Wall shear stress contours during (a) diastole and (b) systole.
From Figure 4.33 the wall shear stress magnitude scale ranges from 0 to 0.7 Pa.

The

cardiovascular phantom represents a healthy male. From Figure 4.38, the highest wall shear
stress during diastole at rest state cycle is observed in femoral section around 0.170 Pa. The
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highest wall shear stress during systole is in the CCA and the femoral section at 0.7 Pa. Also
observed in the Figure 4.38b is that the highest wall shear stress is observed in sections where
there are bends, curves, and branching.

Wall Shear
Stress (Pa)
Figure 4.39. Wall shear stress contour for the coronary arteries.
Figure 4.39 presents the wall shear stress contours for the coronary arteries which are attached to
the aortic valve section. The scale of the wall shear stress for the coronary arteries ranges from 0
to 2 Pa. Similar to the wall shear stress in the neighboring arteries, the highest wall shear stress
occurs around curves and bends. The highest wall shear observed in the coronary arteries is 2 Pa
which is at systole. The reason for the highest wall shear being present in the coronary is
because the coronary arteries have a much smaller diameter than the aorta. The Venturi effect
causes a higher wall shear stress magnitude. Due to continuity, the Venturi effect describes the
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nature of acceleration in flow due to a reduction in area. Continuity states that mass must be
conserved regardless of the increase or decrease in area. The highest wall shear indicated
regions where there is accelerated transport of blood. Previous studies have indicated that wall
shear stress promotes cell growth. It is hypothesized in the present study that the transport of
blood and nutrients promotes cell growth and that wall shear stress is a mere indication of
transport. The most significant take away is that in a normal situation for rest state cycle is that
the range of wall shear stress is from 0 to 2 Pa and that the highest magnitude of wall shear is
present in sections where there are curves, bends, and branching into constituent arteries.
Figure 4.40 present the normal stress contours for the digital cardiovascular phantom.
The contours present the normal stress magnitudes at different times during the cardiac cycle.
Figure 4.40a present the normal stress contour at diastole and Figure 4.35b present the normal
stress contour at systole. Similar to Figure 4.40, the contours are broken into sections due to
regions of varying normal stress in the digital cardiovascular system. The magnitude of the
normal stress is higher in the mid-section of the phantom (aortic section) as appose to the upper
level (cerebral). From Figure 4.40 the normal stress magnitude scale ranges from -0.1 to 0.275
Pa. From Figure 4.40, the highest normal stress during diastole at rest state cycle is observed in
femoral section around 0.0253 Pa. The highest normal stress during systole is in the CCA and
the femoral section at 0.275 Pa. The normal stress is useful because it provides insight on the
level of forces normal to the direction of flow is present. High normal forces can promote
restenosis, penetration/rupture, and dislodging/movement of medical implants.

Figure 4.41

presents the normal stress contours for the coronary arteries. The scale of the normal stress for
the coronary arteries ranges from -0.5 to 1.40 Pa.
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Normal Stress
(Pa)

Normal Stress
(Pa)
Figure 4.40. Normal stress contours during (a) diastole and (b) systole.
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Similar to the normal stress in the neighboring arteries, the highest wall shear stress occurs
around curves and bends. The highest normal stress observed in the coronary arteries is 1.40 Pa
which is at systole.

Normal Stress
(Pa)

(a)

(b)

Figure 4.41. Normal stress contours for the coronary arteries during (a) diastole and (b) systole.

Similar to the wall shear contours, the highest stress is observed in regions where there are
curves and bends. Future studies are needed to confirm the magnitude of stress for healthy and
diseased arteries in full cardiovascular models to determine the effects of local hemodynamics on
global hemodynamics.
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5 CHAPTER 5
Discussion and Future Research
The ultimate goal of the present study was to aid in the development of tools to assist in
the treatment of cardiovascular disease and atherosclerosis.

In the present study a full

cardiovascular experimental phantom and digital phantom (CFD model) was fabricated to study:
(1) the effects of local hemodynamics on global hemodynamics, (2) the effects of transition from
bed-rest to upright position, and (3) transport of dye (drug delivery) in the arterial system.
Computational three dimensional (3-D) models of drug eluting stents implanted into the arterial
wall were studied in addition to patient-specific arterial hemodynamic models and stents design
flow studies. In the case of the drug eluting stent studies, the main conclusion is that using the
diffusivity for the drug analyzed in the present study, the time that it takes for the drug to diffuse
through the entire wall for the implanted stent is approximately 3.5 months. Future studies will
involve implementing internalized reversible binding of the drug to study the effect of unbound
on bound drug diffusion through the artery wall. Future studies will also involve implementing
porosity parametric studies on stent design to evaluate the effect of stent design on drug
diffusion. For postural change studies, future studies will involve implementing coding to
simulate baro-regulation to incorporate the full effect of orthostatic pressure changes and
systematic responses.
For arterial CFD studies, patient-specific CA models were generated from computed
tomography angiography (CTA) scans and modeled for CFD. The simulated flow profiles in the
patient-specific geometries were compared against a simplified carotid bifurcation geometry to
evaluate the efficacy of modeling patient-specific geometries against an alternate simplified
geometry. Models were also evaluated by comparing hemodynamic parametric magnitudes via
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patient-specific and simplified velocity waveforms. The main conclusion in this work is that
dynamic behaviors of blood through the patient-specific carotid bifurcation arterial geometries
based on numerical approaches showed differences when compared to a simplified carotid artery
bifurcation geometry.

For the patient-specific geometries, the velocity gradients near the

stenosis were much higher than those near the sinus. Flow reversal and low WSS was observed
in the sinus region of the patient-specific models. Also, for the simplified geometry, there was a
small region of velocity increase at the stenosis, and very little flow downstream of the stenosis
to the ICA outlet. The major increase of velocity in the simplified geometry was experienced in
the ECA branch of the artery, while in the patient-specific geometries, the reverse is true. The
present study has proven that using simplified arterial geometries results in an exaggeration of
hemodynamic parameters thus confirming the effect of age, gender, and arterial vessel geometry
on hemodynamics.
Future studies will incorporate the moving boundary of the arterial wall, instead of using
rigid wall boundary conditions. A future study consisting of a broad statistical study on the
effect of patient-specific arterial geometry on hemodynamic flow will be conducted. For dye
concentration studies using the cardiovascular phantom, a more accurate study will be conducted
using photo-diodes to measure the dye concentration as function of time non-invasively. In the
case of evaluating the effect of stent design on hemodynamic flow, future studies will also
involve studying the effect of drug deposition into the blood stream.
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